Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Psychology Dissertations

Student Dissertations, Theses and Papers

2009

A Study of the Cognitive Profiles of Medicated and
Nonmedicated Children Diagnosed with Attention
Deficit Hyperactivity Disorder
Amy E. McLaughlin
Philadelphia College of Osteopathic Medicine, Amy_McLaughlin@comcast.net

Follow this and additional works at: http://digitalcommons.pcom.edu/psychology_dissertations
Part of the School Psychology Commons
Recommended Citation
McLaughlin, Amy E., "A Study of the Cognitive Profiles of Medicated and Nonmedicated Children Diagnosed with Attention Deficit
Hyperactivity Disorder" (2009). PCOM Psychology Dissertations. Paper 104.

This Dissertation is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been
accepted for inclusion in PCOM Psychology Dissertations by an authorized administrator of DigitalCommons@PCOM. For more information, please
contact library@pcom.edu.

Philadelphia College of Osteopathic Medicine
Department of Psychology

A STUDY OF THE COGNITIVE PROFILES OF MEDICATED AND
NONMEDICATED CHILDREN DIAGNOSED WITH ATTENTION DEFICIT
HYPERACTIVITY DISORDER

By: Amy E. McLaughlin
Copyright 2009

Submitted in Partial Fulfillment of the Requirements for the Degree of
Doctor of Psychology
August 2009

PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
DEPARTMENT OF PSYCHOLOGY
Dissertation Approval

This is to certify that the thesis presented to us by

on the

:z,o+1, day of

(VJ 0,

7

'

:4(Vl V;

/V1c. l-,VJv",/"I) )Vj

20 () '1, in partial fulfilhnent of the

requirements for the degree of Doctor of Psychology, has been examined and is
acceptable in both scholarship and literary quality.

Committee
Members'
Signatures:
Committee
Members'
Signatures:
George McCloskey, Ph.D., Chairperson
Janet Friedman, Ed.D., NCSP
Daniel H. Ingram, Psy.D.
Robert A. DiTomasso, Ph.D., ABPP, Chair, Department of Psychology

Cognitive Profiles of ADHD Students

iii

Acknowledgements
There are so many people who have contributed to my development as I have
journeyed through the doctoral program at PCOM. First and foremost I would like to
express my sincere gratitude to the members of my dissertation committee. Special
thanks to Dr. George McCloskey, not only for his guidance through the dissertation
process, but also for the many things I have learned from him over the years, through
lectures and informal conversations. Despite his busy schedule, he always made himself
available for consultation. His passion for the field of psychology and dedication to the
profession are truly inspiring.
A special thank you goes to Dr. Janet Friedman for allowing me to continue her
ADHD research and for participating in my project. I look forward to collaborating on a
joint project combining our research in the future. Thank you also to Dr. Dan Ingram for
his involvement in my dissertation study. His time and participation were very much
appreciated.
I have had such a wonderful experience at PCOM and am so grateful to all of
psychology faculty, who are truly leaders and innovators in the field. I have learned so
much during my doctoral studies and have been so inspired by their contributions to our
profession. I am also grateful to members of my cohort who made the doctoral program
such an enjoyable experience. I could not have asked for a better group of classmates
and friends.
A special thank you to those who assisted me with data collection: Rori
Minissale, Susan Clements, Lisa Hain, Lisa Perkins, Gabrielle Wilcox, Mary Sharp-Ross,
Jessica MacKinney, Gerald Smith, Gary Lord, Duane Conrad, Yolanda Stanton, Julie

Cognitive Profiles of ADHD Students

iv

Ribar, Katie Shemanski, Minu Poulose, Vicki Capolarello, Sharise Wilson, Melissa
Stutzman, and Leticia Stauffer. Your assistance made this study possible.
I would like to thank my coworkers and mentors, Dr. Rori Minissale and Dr.
Susan Clements. I am so lucky to work with such talented psychologists, who have
become such wonderful friends. I am forever grateful for your support and
encouragement as I dealt with the challenges of juggling the doctoral program while
working full-time.
Thanks to the faculty and students at the Center for Brief Therapy, especially my
supervisors, Dr. Barbara Golden and Dr. Elizabeth Gosch. My internship at the CBT was
such a wonderful learning experience. I am so grateful for the opportunity to develop my
clinical skills among such experts in the field.
I would not have realized this accomplishment if not for my parents, Jim and
Theresa Smith. They instilled the value of education from an early age. I am eternally
grateful for the sacrifices they made over the years to ensure that I had every possible
educational opportunity. They believed in me and pushed me to do my best, teaching me
that if I just put my mind to it, there is no goal out of my reach.
Most importantly, I would like to thank my husband, Ed, for his unconditional
patience, love and support. Ed has been my biggest cheerleader throughout the process,
celebrating all of my accomplishments along the way, even the small ones, and
encouraging me to keep going in the face of a challenge.

Cognitive Profiles of ADHD Students

v

Abstract
Attention Deficit Hyperactivity Disorder is among the most commonly diagnosed
childhood disorders, with symptoms that can cause significant difficulties in the
educational setting. Deficits related to working memory and processing speed are
thought to be a core feature of ADHD. As such, research using traditional measures of
cognitive functioning has shown that children diagnosed with ADHD tend to perform
poorly on measures of processing speed and working memory, relative to non-ADHD
individuals and relative to measures of other cognitive abilities. Psychostimulant
medication is a common treatment for ADHD and research overwhelmingly supports its
positive impact on behavior and concentration; however, research related to its impact on
cognitive functioning is sparse and findings have been equivocal.
The major purpose of the current study was to determine whether or not there are
significant differences in the cognitive profiles of individuals with ADHD relative to nonADHD controls. Of particular interest was the functioning of children with ADHD on
measures of processing speed and working memory relative to non-ADHD children and
relative to measures of other cognitive abilities. Furthermore, this study was designed to
investigate the effects of medication on the performance of ADHD subjects on measures
of cognitive functioning.
The results of this study found that students with ADHD did perform significantly
lower on measures of processing speed and working memory on the WISC-IV relative to
non-ADHD subjects and relative to measures of verbal and nonverbal reasoning skills.
This lends support to previous research and hypotheses, indicating that working memory
and processing speed deficits are a core feature of ADHD. This study did not find
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significant differences between students who were medicated relative to those who were
not on overall IQ, Index, or Subtest scores of the WISC-IV. On the other hand,
nonmedicated ADHD subjects were more likely than medicated ADHD subjects to
display GAI scores greater than WMI, which provides some support for the positive
effects of medication on working memory, although much more research is needed to
make this claim. No support for positive medication effects on processing speed was
found in this study.
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CHAPTER 1
Introduction
Statement of the Problem
Among the most common (Shaywitz, Fletcher, & Shaywitz, 1995) and most
highly studied neurobehavioral disorders of childhood (Barkley, 1991; Robins, 1992),
Attention Deficit/ Hyperactivity Disorder (ADHD) affects approximately 3% to 8% of
the school-aged population in the United States (American Psychiatric Association, 2000;
Barkley, 1998). Children with ADHD present with attention, impulse control, and motor
activity impairments that cause academic and behavioral difficulties in the educational
setting (Landau & Burcham, 1995). In 1998, the National Institutes of Health (NIH)
assembled a team of experts representative of various professional disciplines from
across the United States for the purpose of reviewing the literature on ADHD and
generating a position paper outlining important diagnostic and treatment issues. The
consensus paper indicated that ADHD represents a major public health concern (National
Institutes of Health, 1998).
Although ADHD is a commonly diagnosed childhood disorder, there are concerns
about the best way to diagnose and treat children with ADHD (Connors, 2000).
Problems with current diagnostic practices are due to the fact that ADHD is primarily
conceptualized as a behavioral disorder; it is often diagnosed on the basis of a parent
interview using behavioral criteria, and parent and/ or teacher rating scales. Behavioral
methods are imperfect measures because of limited inter-rater agreement, given the fact
that expectations and acceptances of child behaviors can vary across settings and have
limited discriminant validity (Hale, How, DeWitt, & & Coury, 2001). In addition, other
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learning and behavioral disorders can co-occur with ADHD. For example, some research
suggests that children with ADHD, Hyperactive-Impulsive Type (ADHD-HIT) are likely
to have comorbid externalizing behavior disorders (Jensen, Martin, & Cantwell, 1997),
but the inattentive type more frequently co-occurs with learning disabilities and
internalizing disorders (Biederman, Faraone, & Lapey, 1992; Jensen et al., 1997; Jensen
et al., 1997; Jensen et al., 1997). Comorbidity with other disorders complicates diagnosis
(Biederman et al., 1992). Given comorbidity issues and the subjective nature of
information gathered from informants, current diagnostic practice for identifying ADHD
is problematic.
In addition to behavioral indications, an emerging body of research points to
potential cognitive indicators of ADHD. Based on his research, Barkley (1998)
conceptualized ADHD as a deficit in behavioral inhibition linked to neuropsychological
abilities. As such, he theorized that ADHD results in cognitive impairments in the areas
of working memory and processing speed. Ruckledge and Tannock (2002) concluded
from their study that neuropsychological deficits such as verbal working memory and
processing speed, rather than behavioral inhibition may be central to a description of
ADHD. Some research has shown that ADHD affects overall levels of performance on
intelligence tests (Barkley, 2000; Mahone et al., 2003). Comparisons of ADHD children
with non-ADHD children in the normative samples of various editions of the Wechsler
Intelligence Scale for Children have revealed differences in overall IQ, as well as on
index and domain scores. Studies have also shown that children diagnosed with ADHD
perform poorly on neuropsychological tests, particularly on measures of processing speed
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and working memory (Kail & Salthouse, 1994; Kail, 2000; Kalff et al., 2002; Karatekin
& Asarnow, 1998).
Psychostimulant medication is perhaps the most common form of intervention for
children in the United States who have ADHD (Purdie, Hattie, & Carroll, 2002), which
makes the effects of psychostimulant medication relevant to clinicians and educators
alike. Barkley (2006) suggested that medication has the most salient effect upon behavior
and concentration, with performance on intelligence tests much less affected by
medication. In line with Barkley’s hypothesis, there is much research supporting the
efficacy of stimulant medication for improvement in behavioral symptomatology such as
attention, concentration, and hyperactivity (Barkley, 1998; DuPaul, Barkley, &
McMurray, 1994; Hale & Fiorello, 2004; Pelham & Milich, 1991). Research
investigating the effects of medication on cognitive functioning is sparse; few utilize fullscale tests of intelligence to measure medication effects. Studies evaluating cognitive
effects of medication have yielded inconsistent results.
Much of the research investigating the impact of ADHD on cognitive functioning
has pointed to deficits in processing speed and working memory. Some research has
suggested that as the demands on processing speed and working memory have increased
on the Wechsler scales, the IQ’s of ADHD students have been found to decrease
(Zimmerman & Woo-Sam, 1997). In fact, Mahone and colleagues (2003) found that the
ADHD group performed more poorly on the WISC-III than on the WISC-R. The current
version of the Wechsler scales for children (WISC-IV) places even greater demands on
processing speed and working memory capacities, which has implications for the
cognitive performance of children with ADHD. During the initial validation of the
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WISC-IV, 89 children ages 8-13 with a diagnosis of ADHD were tested. Data related to
medication status was gathered, but the data for medicated and non-medicated children
was not analyzed separately. Compared with matched controls, ADHD group mean
differences for Processing Speed Index (PSI) scores reflected a moderate effect size.
Small effect sizes were reported between the Verbal Comprehension Index (VCI),
Working Memory (WMI), and Full Scale Intelligence Quotient (FSIQ) scores. At the
subtest level, the largest effect sizes for group mean differences were found on the
Coding and Arithmetic subtests. Other WMI and PSI subtests had modest or small effect
sizes. Because medicated and nonmedicated students were grouped together, it is
possible that improvement in functioning because of medication use masked some of the
processing speed and working memory deficits present in the nonmedicated students
(Friedman, 2006). In 2006, Friedman utilized two samples of male students diagnosed
with ADHD, one medicated and one not medicated, and matched them with non-ADHD
controls from the WISC-IV normative sample in order to expand on the validation studies
and to explore the relationship between medication and cognitive functioning. The only
significant index/ factor scores differences found between groups occurred on the
Working Memory Index, with the nonmedicated ADHD group performing more poorly
than the non-ADHD matched controls. At the subtest level, the nonmedicated ADHD
group performed significantly lower on DS than the medicated ADHD group and nonADHD controls. Lower performances on the Working Memory Index relative to nonADHD controls, however, did not carry over to a significant difference in FSIQ as was
predicted. Friedman (2006) further noted that preliminary analyses of the data collected
suggests potential differences between ADHD and control groups in reference to the
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degree of score differences between Verbal Comprehension and Working Memory Index
scores and recommended that future research be conducted in this area. In addition, more
research is needed to investigate the impact of psychostimulant medication on cognitive
functioning.
Purpose of the Study
The major purpose of the current study is to determine whether or not there are
significant differences in WISC-IV FSIQ, Index scores and Subtest scores within
individuals with ADHD relative to non-ADHD controls. Furthermore, this study will
investigate the performance of ADHD and non-ADHD subjects on measures of working
memory and processing speed, relative to measures of other cognitive abilities, such as
verbal and nonverbal reasoning skills. Finally, this study will investigate the impact of
medication status (medicated versus nonmedicated) on Index and Subtest score
differences in individuals with ADHD.
Literature Review
Origins of ADHD. References to individuals with problems related to inattention,
hyperactivity, and poor impulse control are noted in literature dating back to
Shakespeare, although it did not become a serious clinical interest until 1902 when it was
introduced by English physician George Still to the Royal Academy of Physicians
(Barkley, 1997a). Interest in children with these characteristics surfaced in North
America around 1917-1918, at the same time as the great encephalitis epidemic, because
children surviving these brain infections demonstrated characteristics similar to the
condition that is known today as ADHD (Barkley, 1997a). Over time, however,
researchers began to observe these behavioral problems associated with brain damage or
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mental retardation in children without evidence of brain injury or retardation. The
diagnostic term “minimal brain damage” and later “minimal brain dysfunction” was
applied to these cases.
As researchers began focusing attention on the hyperactivity and poor impulse
control exhibited by these children, the condition became known as “hyperkinetic
impulse disorder” and later “hyperactive child syndrome” in an effort to provide a more
descriptive view of the disorder (Barkley, 1997a; Barkley, 2000). Although many
clinicians and researchers held onto the belief that the condition had a neurological basis,
psychiatry remained influenced by the psychoanalytic view that children’s mental
disorders were primarily a reaction to various environmental factors (Barkley, 1997a).
As a result, in 1968 this disorder was introduced into the Diagnostic and Statistical
Manual of Mental Disorders (DSM-II: American Psychiatric Association [APA], 1968)
under the label of “Hyperkinetic Reaction of Childhood.” Diagnostic criteria for this
condition included observable disruptive behavioral excesses. Coinciding with scientific
advancements in the field of ADHD, each subsequent edition of the DSM has
substantially revised both the nomenclature and nosology of this disorder (Schwean &
Saklofske, 2005). The 1980 revision of the DSM (DSM-III), reflected advances in
research, demonstrating that subtle cognitive deficits in response inhibition and attention
were more prominent and reliable indicators of ADD than were motor excesses; it also
suggested subtypes differentiated by the presence or absence of hyperactivity (Schwean
& Saklofske, 2005). This differentiation of subtypes was abandoned, however, in the
1987 edition (DSM-III-R) because of a lack of empirical support, and instead a general
attention-deficit hyperactivity disorder (ADHD) characterized by developmentally
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inappropriate degrees of inattention, impulsivity, and hyperactivity was included
(Schwean & Saklofske, 2005). In line with the findings of factor analytic studies
supporting the differentiation of two factors (inattention and hyperactive-impulsive) and
with studies documenting the external validity of subgroups differentiated by these
factors (Lahey et al., 1994), the current version of the DSM (DSM-IV-TR, 2000)
recognizes three subtypes of ADHD: ADHD, predominantly inattentive type (ADHDIT); and ADHD, predominantly hyperactive-impulsive type (ADHD-HIT); and ADHD,
Combined Type (ADHD-CT).
Current diagnostic criteria for ADHD, as established by the DSM-IV-TR (APA,
2000), includes the presence of at least 6 of 9 symptoms either of inattention and/ or
hyperactivity/ impulsivity that have been present before age 7; have persisted for at least
6 months; are more frequent and severe than is typical for the age group; manifests in
multiple settings, and adversely affects functioning. The 9 potential inattentive
symptoms are as follows: (a) fails to give close attention to details; (b) has difficulty
sustaining attention in tasks or play; (c) does not seem to listen when directly spoken to;
(d) does not follow through on instructions and fails to complete school work, chores, etc.
(e) has difficulty organizing tasks and activities; (f) avoids, dislikes, or resists engaging in
tasks requiring sustained mental effort; (g) loses things necessary for tasks; (h) is easily
distracted by extraneous stimuli; and (i) is forgetful. The 9 hyperactive-impulsive
symptoms include the following: (a) fidgets with hands or feet or squirms in seat; (b)
leaves seat in situations in which remaining seated is expected; (c) runs about or climbs
excessively (in adolescents/ adults may be a sense of restlessness); (d) difficulty engaging
in activities quietly; (e) is frequently “on the go” or appears as if “driven by a motor”; (f)

Cognitive Profiles of ADHD Students

8

talks excessively; (g) blurts out answers before a question is completed; (h) has difficulty
awaiting turn; and (i) interrupts or intrudes on others. The DSM-IV definition of ADHD
reflects important advances in ADHD knowledge; however, it fails to account for
important changes that can occur during the course of development, such as a reduction
of hyperactive symptoms over time (Power & DuPaul, 1996).
ADHD is most commonly diagnosed during elementary school when school
adjustment is compromised (APA, 2000). In the majority of cases, the disorder remains
relatively stable throughout early adolescence, and symptoms such as motor hyperactivity
seem to remit during late adolescence and adulthood (APA, 2000). A minority of adults,
however, continue to experience a full range of symptoms into mid-adulthood, yet others
will retain only some of the symptoms.
Prevalence of ADHD. According to the DSM-IV-TR, the prevalence of ADHD in
school-age children is estimated at 3% to 7% (APA, 2000). Reported rates vary
depending on methodology, diagnostic system utilized, and the nature of the population
studied. When looking at community samples, Rowland, Lesesne and Abramowitz
(2002) reported a prevalence of 2% to 18%. There has been a rapid rise in the prevalence
rates of ADHD (Purdie, Hattie, & Carroll, 2002). In fact, evidence suggests that the
prevalence of ADHD as defined in the DSM-IV may be somewhat greater than the
prevalence based on the DSM-III-R criteria because of the inclusion of the Predominantly
Hyperactive-Impulsive and Predominantly Inattentive Types (APA, 2000). Robison and
colleagues (1999) found that this increase in diagnosis coincided with a 2.9-fold increase
in the number of ADHD individuals who had been prescribed stimulant medication. In
2003, the United States National Survey of Children’s Health (NSCH) found that
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approximately 4.4 million or 7.8% of children ages 5 to 17 have been diagnosed with
ADHD. Of these children, 2.5 million or 56% reported taking medication for the
disorder. This survey also found that reported ADHD increased with age, and was
significantly higher for children greater than 9 years of age than for children aged 4 to 8
years. Regardless of gender, overall medication by age patterns were curvilinear, with
the prevalence of medication highest in children aged 9 to 13, compared with younger
and with older children (NSCH, 2003).
ADHD is known to occur in various cultures, although there are variations in the
reported prevalence rates among Western countries; this is likely related to different
diagnostic practices than to differences in clinical presentation (APA, 2000).
International cross-cultural studies (i.e., (Anderson, Williams, McGee, & Silva, 1987;
Brewis, Schmidt, & Meyer, 2001) suggest that prevalence rates for ADHD worldwide are
similar to US rates.
In terms of gender, ADHD appears to be more common in males than in females,
with a male-to-female ratio ranging from 2:1 to 9:1, depending on the subtype (the
gender ratio is hypothesized to be less pronounced in ADHD-IT) and setting (APA,
2000). Male to female ratios in community samples have been found to be 3:1, but the
ratios have ranged from 6:1 to 9:1 in clinic-referred samples (Gaub & Carlson, 1997).
Rates of treatment for ADHD followed the same pattern as noted for diagnosis, with
males of all ages more likely to take medication for their ADHD diagnosis.
Studies comparing the symptomatology of ADHD in girls versus boys found that
girls displayed lower levels of hyperactivity, lower rates of comorbid conduct disorders,
lower rates of other externalizing behavior, but greater intellectual impairment
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(Biederman et al., 1999; Gaub & Carlson, 1997). On the other hand, a more recent study
conducted by (Hartung et al., 2002) found that boys and girls ages 3 to 7 years with a
diagnosis of ADHD did not differ on many factors, including internalizing symptoms,
academic achievement, subtype prevalence, and cognitive abilities.
The NSCH (2003) found that within the United States the prevalence of ADHD
diagnosis is higher among non-Hispanic, primarily English- speaking, and insured
children. Prevalence rates were also much higher in families in which the most highly
educated adult completed 12 years of education/ high school graduate, compared with
children in families in which the most highly educated adult had either a higher or lower
level of education (NSCH, 2003). Prevalence rates of ADHD among nonwhite,
American ethnic minority groups have not been established and little research has been
conducted to describe ADHD in ethnic and racial groups (Kendall & Hatton, 2002).
Therefore, ADHD has been characterized as a primarily white, middle class disorder,
because the majority of the research has been conducted with this population.
Etiology of ADHD. The exact causes of ADHD are unknown at this time;
however, there are several factors that appear to be implicated, because they have been
shown to be related to increased risk for ADHD in children. The causal factors that have
received the greatest attention and support in the literature are genetic factors and
biological factors (i.e., those that have a direct affect on brain development or
functioning) (Barkley, 1997a). Research has provided little support for psychosocial
factors as contributing to the development of ADHD (Barkley, 1997a). In fact, it has
been posited that links found between poor child management by a parent and ADHD
may in fact be more attributable to the parent’s own ADHD (a genetic factor) than to the
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environment (Frick & Jackson, 1993). Although Barkley (1997), a major theorist in the
field of ADHD, does not give much attention to psychosocial factors, given the lack of
support in the research; however, he does suggest that environment can play a role in
shaping and molding the nature and severity of the biologically-based vulnerability to
poor inhibition. In addition, he notes that the risk for the development of comorbid
disorders with ADHD (i.e., ODD, CD, anxiety, and depression) is highly correlated with
family environmental factors. Thus he concludes that environment does not play a
primary role in causation; however, it does in determining outcome.
Neurological Factors. Theories of the neurological factors related to ADHD have
been developed, based on similarities noted between the symptoms of ADHD and those
produced by lesions or injuries to frontal lobes, and more specifically the prefrontal
cortex (Benton, 1991; Heilman, Voeller, & Nadeau, 1991; Mattes, 1980). Deficits in
sustained attention, inhibition, regulation of emotion and motivation, and the organization
of behavior over time were observed in individuals with injuries to the prefrontal region
of the brain (Gratton & Eslinger, 1991). There is also other evidence to support a
neurological basis of ADHD. For example, ADHD symptomatology is persistent with an
early onset; it has been associated with other developmental disorders that are believed to
arise from neurological factors; it has a significant relationship to adversities during the
pre- and postnatal periods, and symptoms tend to improve dramatically with the use of
stimulant medication (Barkley, 1997a). In addition, ADHD subjects have been
repeatedly found to perform poorly on neuropsychological tests associated with
prefrontal lobe functions including inhibition, persistence, planning, working memory,
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motor control and fluency, and verbal fluency (Barkley, DuPaul, & McMurray, 1990;
Barkley, 1997b)(Barkley, Grodzinsky, & DuPaul, 1992; Goodyear & Hynd, 1992).
More recent research suggests that the right prefrontal cortex, caudate nucleus and
globus pallidus are typically smaller in children with ADHD, indicating problems with
connectivity between the brain regions that modulate attention, stimulus processing, and
impulsivity (Dophide, 2001). Hale and Fiorello (2004) describe ADHD as a frontalsubcortical disorder. Frontal-subcortical abnormalities, such as asymmetric/ dysmorphic
conditions (Hynd, Semrud-Clikeman, Lorys, Novey, & Eliopulos, 1990), abnormal
electrical activity (Novak, Solanto, & Abikoff, 1995), and decreased cerebral blood flow
(Ernst et al., 1994; Lou, Henriksen, & Bruhn, 1984; Lou, Henriksen, Bruhn, Borner, &
Nielsen, 1989; Zametkin et al., 1993) have been found in children with ADHD. Although
the research has overwhelmingly supported a link between ADHD and frontal lobe
impairment, more research is needed to determine differences across subtypes of ADHD.
The few studies that have attempted to investigate frontal lobe impairment across ADHD
subtypes have not yielded consistent results. For example, O’Driscoll and colleagues
(2005) found impairments in the executive functions of motor planning and response
inhibition with ADHD-CT, but not ADHD- IT boys, and Geurts, Verte, Oosterlann,
Roeyers, and Sergeant (2005) found similar performance between ADHD-IT and ADHDCT subtypes on measures of executive function.
Theoretical Conceptualizations of ADHD
Over the years, ADD has been subject to many reconceptualizations,
redefinitions, and renamings (Lahey et al., 1988) because of the considerable
heterogeneity in etiology, cognitive, academic, psychological, and family correlates;
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clinical courses; and outcomes, and intervention responses among children with this
disorder (Schwean & Saklofske, 2005). Because of this, efforts have been made to
delineate more homogeneous subgroups. There has been particular controversy about
whether or not the IT and HIT/ CT are actually subtypes of a single disorder or actually
two distinct separate disorders (Cantwell & Baker, 1992).
ADHD was initially conceptualized as excessive motor activity related to minimal
brain dysfunction; however, recent advances in medical technology have revised the
causal explanatory hypotheses of ADHD (Schwean & Saklofske, 2005). Specifically, this
research has implicated the prefrontal-striatal network and its interconnections with other
brain regions (Barkley, 1998). Two major theories, Barkley’s (Barkley, 1997b; Barkley,
1997a) disinhibition model, and Rapport and colleagues’ (Rapport, Chung, Shore,
Denney, & Isaacs, 2000; Rapport, Chung, Shore, & Isaacs, 2001) working memory
model, have followed from this research.
Disinhibition Model. Barkley (1997) asserts that ADHD is not primarily a
disorder of attention, but rather a developmental disorder of behavioral inhibition that
hinders the development of effective self-regulation. He defines behavioral inhibition as
three interrelated processes which include: inhibiting the initial response; stopping an
ongoing response, and interference control (not becoming distracted by competing events
and responses). He further postulates four neuropsychological abilities (nonverbal
working memory; internalization of speech; self-regulation of affect; motivation and
arousal; and reconstitution), which are considered executive functions that rely partially
on behavioral inhibition for effective execution. Therefore, the primary impairment in
behavioral inhibition leads to secondary impairments in executive functions. Together,

Cognitive Profiles of ADHD Students

14

these primary and secondary impairments lead to impairment in a fifth area, the motor
control system, which manifests as “decreased effectiveness in motor/ behavioral control
or in guidance by internally represented information and self-directed action” (Barkley,
1997a). Self-control, which is dependent upon inhibition, is defined as any response or
chain of responses that occur within an individual in order to alter the probability of
subsequently engaging in an action in order to maximize both short and long term
outcomes (Barkley, 1997a). These self-directed responses that occur during a delay in
response are thought to become progressively more covert over the course of
development. The self-directed actions that an individual utilizes to self-regulate are
known as executive functions. Behavioral inhibition and self-regulation and its
associated executive functions are thought to be mediated by the prefrontal cortex of the
brain and its interconnections with the striatum (Barkley, 1997a). It is important to note
that Barkley (Barkley, 1997a; Barkley, 2000) clarifies the fact that his model does not
apply to those with ADHD-IT, which he suggests is qualitatively different from ADHDHIT and ADHD-CT.
Working Memory Model. Rapport and colleagues worked from the following
conceptual model of ADHD:
Biological influences (e.g., genetics) give rise to individual differences in the
functional properties of neurobiological systems (e.g., dopaminergicnoradrenergic neurotransmission) that are etiologically responsible for the core
psychological (cognitive and behavioral) features of ADHD. Peripheral
(secondary) features are conceptualized as causal by-products of core features
(Rapport et al., 2000)
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The peripheral or secondary features referred to in this model include difficulties that are
thought to be caused by the more primary features of the disorder such as academic
underachievement, inadequate social skills, low frustration tolerance and strained family
relationships. Rapport and colleagues, therefore, argue that the most effective
interventions will be those aimed at core deficits, because treatment-related improvement
in core domains should correspond with gains in peripheral areas. Considering this
model, however, Rapport and colleagues (2000; 2001) found that gains made in these
three core areas (attention, self-control, and hyperactivity) accounted for only 20% of
improvement noted in academic achievement (the peripheral variable). Based on this
finding and on other research which had been conducted, they proposed a model of
ADHD, positing the idea that working memory plays a crucial role in the organization of
behavior. As such, organized responding is dependent upon the capacity of working
memory to perform three functions. These functions include: (1) generating and holding
representations of input stimuli, (2) searching memory for matches, and (3) accessing and
holding on to appropriate behavioral responses to input stimuli. Disruption to any of
these working memory processes should result in tangential or random responses to
environmental stimuli. This model is purported to account for the disorganized behavior
that is characteristic of children with ADHD.
A second component to this model posits the idea that failure of working memory
not only causes disorganized behavior but also compels children to seek stimulation by
redirecting their attention to other environmental stimuli. This inability to maintain
working memory representations is speculated, therefore, to lead to behavior serving to
increase the rate at which input is delivered to working memory in order to compensate
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for the rapid fading of representations. Another potential hypothesis suggested that this
redirection of attention is a form of escape from monotonous or extremely demanding
tasks. This stimulation- seeking behavior is observed by others as hyperactive and
impulsive. Based on this proposed model, impulsive acts are considered disorganized
patterns of behavior that manifest from an inability to maintain working memory
representations either of the stimulus context, of relevant memory traces, or of both.
Therefore, considering the consequences of behavior is considered by these researchers to
be highly dependent upon working memory. In contrast to Barkley’s model, Rapport and
colleagues view impulsivity and hyperactivity as causal by-products and working
memory as a core causal cognitive process.
Although there is disagreement and debate over the core deficit of ADHD, there is
considerable agreement that these individuals display disorganized behavior, problems
with self-control, and weaknesses in cognitive areas such as working memory and
processing speed. Much research has been devoted to exploring the cognitive deficits
present in individuals with ADHD.
Cognitive Functions and ADHD
Although diagnostic criteria for ADHD are primarily behavioral in nature,
research suggests that cognitive deficits, such as impairments in attention, response
inhibition, and perceptual-motor speed are also core features of the disorder (Barkley et
al., 1990; Sykes, Douglas, & Morgenstern, 1973). In 1992, Barkley, Grodzinsky, and
DuPaul reviewed 22 neuropsychological studies of the frontal lobe functions of children
with ADHD, both with and without hyperactivity. Based on this review, they concluded
that children with ADHD present with cognitive deficits in sustained attention and
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inhibitory control, which they related to subtle frontal lobe impairments in the brain as
measured on neuropsychological testing. Lahey et al. (1998) found neuropsychological
impairment with ADHD manifested as deficits in perceptual-motor processing speed.
Based on the literature, many researchers have characterized ADHD as a condition
involving executive control difficulties that impact working memory and processing
speed (DeFockert, Rees, Frither, & Lavie, 2001; Weiler, Bernstein, Bellinger, & Waber,
2000; Weiler, Bernstein, Bellinger, & Waber, 2002).
Working Memory. Working memory is the ability to maintain information
actively in conscious awareness while performing some operation or manipulation with it
and producing a result (Wechsler, 2003). Studies conducted by Fry and Hale (1996) and
Perlow, Jettuso & Moore (1997), have shown that working memory is an essential
component of fluid reasoning and higher order cognitive processes, and is related to
achievement and learning. DeFockert and colleagues (2001) suggested that the greater
the demands on working memory, the more likely an individual is to become distracted
by irrelevant information. They hypothesized that either of these impairments in working
memory gives rise to distractibility or vice versa.
The theoretical and functional structure of working memory is still under debate
(Alloway, Gathercole, & Pickering, 2006; Engle, Tuholski, Laughlin, & Conway, 1999;
Miyake, Friedman, Rettinger, Shah, & Hegarty, 2001). One model suggests that there are
two separate pools of modality-specific resources for storing and manipulating auditoryverbal and visual-spatial stimuli (Shah & Miyake, 1996). Another model argues that
working memory is composed both of visual (visuospatial sketchpad) and of verbal
(phonological loop) storage systems that are regulated and controlled by a central
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executive component (Baddeley, 1986). Finally, another model proposes four separable
components including the visual-spatial storage of information; the visual-spatial
manipulation of information; the auditory-verbal storage of information, and the
auditory-verbal manipulation of information (Friedman & Miyake, 2000; Miyake et al.,
2001). Baddeley’s (1986) tripartite model has been the most influential (Martinussen,
Hayden, Hogg-Johnson, & Tannock, 2005) and continues to be supported by recent
research (Alloway et al., 2006; Bedard, Jain, Hogg-Johnson, & Tannock, 2007).
Working memory impairments have been linked with ADHD theoretically
(Barkley, 1997b; Castellanos & Tannock, 2002; Rapport et al., 2001), as well as
empirically (Martinussen et al., 2005; Willcutt, Doyle, Nigg, Faraone, & Pennington,
2005). Working memory functions are thought to be highly dependent on frontostriatal
brain regions (Bunge, Ochsner, Desmond, Glover, & Gabrieli, 2001; Kondo, Morishita,
& Osaka, 2004; Lewis, Dove, Robbins, Barker, & Owen, 2004; Smith & Jonides, 1999)
and the cerebellum (Gottwald, Mihaljlovic, Wilde, & Mehdorn, 2003; Lalonde, 2003).
Furthermore, depending on the modality of the central executive tasks, different neural
structures are activated, with verbal tasks more lateralized to the left and spatial to the
right (Fletcher & Henson, 2001). Research has also demonstrated that dopaminergic and
noradrenergic systems modulate working memory processes (Arnsten, 2001; GoldmanRakic, Castener, Svensson, Siever, & Williams, 2004).
In 2005, Martinussen and colleagues conducted a meta-analysis to determine the
empirical evidence for working memory deficits in children and adolescents with ADHD.
Based on their analysis of 26 studies published between 1997 and 2003, they found that
children with ADHD did exhibit deficits in multiple components of working memory that
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were independent of comorbidity with language learning disorders and weaknesses in
general intellectual ability. The overall effect sizes obtained were greater for spatial
storage and spatial central executive working memory than those obtained for verbal
storage and verbal central executive control; however, the authors cautioned that findings
should be considered exploratory in nature, given the small number of studies included,
particularly in the spatial domains. Nonetheless, the finding that working memory
deficits are present in ADHD provides support for frontostriatal and dopamine-system
dysfunction in ADHD. It was further speculated that the academic difficulties
experienced by children with ADHD are related to working memory deficits, rather than
to inattention alone.
Karatekin and Asarnow conducted a study in 1997 to investigate verbal and
spatial working memory functioning in children with ADHD and children with
childhood-onset schizophrenia and matched normal controls. Their results showed that
both the ADHD children and the schizophrenic children displayed deficits in verbal and
spatial working memory.
Cornaldi and colleagues (2001) set out to investigate whether or not children with
ADHD would manifest deficits in working memory related to intrusion errors. They
utilized auditory working memory measures in this study. Their results showed that
children with ADHD have working memory problems only when a high degree of control
is required. No significant problems were noted in ADHD subjects on working memory
tasks that required the individual to recall all of the material presented. These results
supported findings that a working memory difficulty in children with ADHD can be
related to inhibition problems. ADHD children are not capable of suppressing
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information that initially has to be encoded and processed, but then must subsequently be
excluded from memory. In a second study, Cornaldi and colleagues (2001) looked
specifically at visuospatial working memory problems in children with ADHD. The
results supported the theory proposed by Baddeley (1986) that ADHD children have
deficits in active control processes, also known as the Central Executive component of
the Working Memory system. These deficits are subsumed under the category of
Executive Dysfunction, which have been linked with pre-frontal lobe functioning
(Cornaldi et al., 2001). Thus, this study is consistent with the assumption that the
executive dysfunction is a core component of ADHD associated with prefrontal lobe
dysfunction. This study also supported Cornaldi and Vecchi’s (2000) view that the active
working memory deficit implicated in children with a general control problem, such as
ADHD, is cross-modal, but can be modality-specific for individuals with other types of
learning disabilities.
Processing Speed. In addition to working memory, many studies have also found
that ADHD students tend to perform less well on measures of processing speed than
nonclinical controls (Prifitera & Dersh, 1993; Rucklidge & Tannock, 2001; Tiholov,
Zawallich, & Jansen, 1996; Weiler et al., 2000; Weiler et al., 2002). Clinical research in
developmental cognitive psychology has suggested a dynamic relationship between
working memory, processing, and reasoning. Given the fact that working memory and
processing speed are thought to be interrelated, it is not surprising that in addition to low
scores on measures of working memory, ADHD individuals tend to score lower on
processing speed measures.
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Kail and Salthouse (1994) relate processing speed to mental capacity, and
therefore argue that mental capacity can be conceptualized in terms of the speed with
which an individual processes many types of information. Research has consistently
related speed of information processing, not only to mental capacity, but also to
reasoning by the conservation of cognitive resources and the efficient use of working
memory for higher order reasoning tasks (Kail & Salthouse, 1994; Kail, 2000). Kail and
Salthouse (1994) assert that cognitive change over the lifespan is mediated by change in
processing speed and plays a key role in one’s ability to think, reason, and remember.
For example, they have found that on a wide range of motor, perceptual, and cognitive
tasks in which participants must respond rapidly, the following pattern emerges: 8- to 10year-olds responded at a speed that is 5 to 6 standard deviations below the average speed
for young adults; and that 12- and 13-year olds respond at a rate more than one standard
deviation below the average for young adults (Kail, 1991). It is theorized that a global
mechanism limits the speed with which children and adolescents process information.
This global mechanism is not specific to particular tasks or domains, but rather is a
fundamental characteristic of the developing information-processing system (Kail, 2000).
In addition to age differences, processing speed has been found to be sensitive to
neurological conditions such as traumatic brain injury (Donders, 1997). Given the
relationship between processing speed and neurological development, as well as the
research supporting the relationship between working memory, processing speed, and
reasoning, Kail and Salthouse (1994) advocate for the importance of the assessment of
processing speed in children. Rapid processing of information is hypothesized to reduce
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the demands on working memory, which facilitates reasoning. As such, processing speed
is a construct often included on standardized measures of intelligence.
IQ Tests and Effect of Content on ADHD Subjects
Most intelligence tests utilized today yield a general Intelligence Quotient (IQ)
score that is derived from a series of tasks that measure various aspects of cognition. For
example, the Wechsler Intelligence Scale for Children- Third Edition (WISC-III) yields a
Full-Scale IQ (FSIQ) and four index scores which include the Verbal Comprehension
Index (VCI), Perceptual Organization Index (POI), Processing Speed Index (PSI), and
Freedom from Distractibility Index (FFD). These scores are derived from a series of
subtests that measure verbal ability, nonverbal abilities, processing speed, and working
memory. The effects of ADHD on IQ can be influenced by the nature and content of the
tasks utilized to assess intelligence.
ADHD and the Wechsler Scales
Given the evidence for cognitive deficits related to ADHD, there is support for the
use of the Wechsler scales for diagnostic purposes, because they are purported to measure
cognitive skills such as processing speed, memory, attention, and visual organization
(Sattler, 1992). Since their original publication in 1949, the Wechsler scales have been
widely used (Kampaus, 1993). The primary use of these scales has been diagnostic in
nature (Wechsler, 1991), although the appropriateness of this utilization has been the
topic of considerable debate, particularly related to the identification of children with
ADHD (Schwean & Saklofske, 1998). The diagnostic utility of the WISC for the
identification of children with ADHD has been empirically tested through a variety of
approaches (Assesmany, McIntosh, Phelps, & Rizza, 2001).
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One such approach has been to compare the mean performance of children with
ADHD to control groups (Schwean & Saklofske, 1998). In general, research of this type
has found that students with ADHD demonstrate lower overall levels of intellectual
functioning than their non-ADHD counterparts (Barkley, 1990; H. S. Goldstein, 1987).
As part of a larger study, Barkley et al. (1990) compared intellectual functioning of
children with ADHD to non-ADHD controls, using the WISC-R. Their findings indicated
that ADHD students both with and without the hyperactivity component had significantly
lower mean FSIQ scores than non-ADHD controls. Goldstein (1987) found that students
rated by teachers as inattentive had significantly lower WISC scores than non-ADHD
controls. Additionally, he found a significant difference between children with
hyperactivity and aggression versus children with inattention; hyperactive and aggressive
children had higher IQ’s than inattentive children.
Research conducted with the WISC-III continued to support the findings that
children with an ADHD diagnosis obtain lower overall scores when compared with nonADHD controls (Anastopoulos, Spisto, & Maher, 1994; Barkley, 1990; Faraone et al.,
1993; Tripp, Ryan, & Peace, 2002; Zhuang, Liu, & Zhang, 2001). According to Barkley
(1998), the behavioral inhibition impairments and the related executive dysfunction
associated with ADHD could be expected to have a small but significant and negative
impact on IQ, particularly Verbal IQ.
During the standardization studies, the WISC-III (Wechsler, 1991) was
administered to a sample of 68 children ages 7 to 16, with documented ADHD. This
sample demonstrated mean IQ scores near the normative average, with low mean scores
on the Processing Speed and Freedom from Distractibility scales. Tiholov, Zawallich,
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and Janzen (1996) used a sample of 311 students to determine whether or not the WISCIII Processing Speed Factor could be used to distinguish between groups of children with
different types of problems. Their finding, which was related to subjects with ADHD,
found that those who were also diagnosed with visual motor integration difficulties
demonstrated perceptual discrimination difficulties manifested through significantly
lower scores on the Symbol Search subtest, but not lower on the Coding subtest than
participants without ADHD and visual motor integration problems.
Weiler et al. (2000) set out to study the neuropsychological profile of students
with ADHD, primarily inattentive type. Their subjects included 82 children referred for
school-related problems. Processing speed was assessed with a number of measures
including the WISC-III Coding and Symbol Search subtests. Findings suggested that
children with learning problems, in general, exhibited problems on measures of
processing speed, and that those diagnosed with ADHD were particularly vulnerable.
Weiler and colleagues replicated this study in 2002, this time using computer-based
measures to evaluate information processing. They utilized a visual search task and an
auditory processing measure. As they predicted, based on their earlier research, the
ADHD-IT students performed more poorly than non-ADHD subjects on the visual search
task, but not the auditory processing task. Children with reading disabilities had the
reverse pattern. From these results, they concluded that children with ADHD-IT do not
have global information processing deficits; rather they process visual information more
slowly, especially when the cognitive load is increased and they are required to integrate
multiple component operations. ADHD-IT subjects did not perform more slowly on
simple reaction time measures.
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Researchers have also utilized the WISC-III to evaluate auditory working memory
processes in children with ADHD. Results of some studies suggest that FFD for ADHD
children, although for the vast majority not a significant weakness relative to peers, was
significantly lower relative to other WISC-III factor scores (Anastopoulos, Spisto, &
Maher, 1994; Reinecke, Beebe, & Stein, 1999) or FSIQ (Mayes, Calhoun, & Crowell,
1999). Specifically, Anastopoulos and colleagues found that the FFD factor index was
significantly lower than the VC and PO factor scores within a small clinical sample
(n=40) with ADHD. Analysis at the individual level, however, failed to yield these same
differences for many of the children. A study conducted by Reinecke and colleagues
(1999) utilized a larger sample (n= 200) and also found differences between FFD and
other factor scores; however, correlational analyses failed to support the validity of the
FFD as a measure of attention. An even larger study (n= 301) by Krane and Tannock
(2001) yielded similar findings, with results again suggesting a limited ability to predict
ADHD because of high false-negative rates within the ADHD group and high falsepositive rates within the clinical and nonclinical comparison groups.
Although the aforementioned studies have provided useful information regarding
the cognitive functioning of children with ADHD, they have limited diagnostic utility,
given the fact that the cognitive patterns of children with ADHD are similar to the
patterns exhibited by children with other educational disabilities (Newby, Recht,
Caldwell, & Schaefer, 1993; Teeter & Smith, 1993). Furthermore, the analyses were
conducted using group mean differences, which limits the ability to predict patterns of
individual performance (Assesmany et al., 2001).
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Some studies have examined the subtest level for patterns among ADHD students.
For example, Saklofske, Schwean, Yackulic and Quinn (1994) found that in their sample
of 45 children diagnosed with ADHD, the Processing Speed subtests of Symbol Search
and Coding were among the lowest subtest scores. Reliable research conducted with the
earlier versions of the WISC in the ADHD population found low mean scores on the
Arithmetic, Coding, Information, and Digit Span subtests, a pattern that came to be
referred to as the ACID profile (Dykman, Ackerman, & Oglesby, 1980; Prifitera &
Dersh, 1993).
Standardization studies of the WISC-III (Wechsler, 1991) demonstrated that the
lowest mean subtest scores for students with ADHD occurred on the Coding and Digit
Span subtests. In addition, the WISC-III standardization studies included further
analysis, considering the ACID profile. An ACID composite score was calculated, based
on Arithmetic, Coding, Information, and Digit Span subtest scores. Findings indicated
that the full ACID profile was exhibited in the scores of 11.8% of the ADHD sample,
compared with 1.1% of the standardization sample. The partial ACID profile (based on
any three of the ACID subtests) was demonstrated by 27.9% of the ADHD sample,
compared with 5.6% of the standardization sample. Based on these results, it was
recommended that when the ACID profile is present, an attention-deficit disorder should
be considered; however, it was also cautioned that if not present, ADHD should not be
ruled out, given the fact that a majority of children with ADHD in this sample did not
exhibit the ACID profile.
With the third revision of the WISC, a new performance profile pattern for
ADHD was proposed to reflect the addition of the Symbol Search subtest (Kaufman,
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1994; Mayes, Calhoun, & Crowell, 1998). This new profile, SCAD, reflected a pattern of
lower scores on the Symbol Search, Coding, Arithmetic, and Digit Span subtests. In
1999, Mayes, Calhoun and Crowell analyzed the WISC-III data in clinical samples of
ADHD children and normally developing children. They found that for the ADHD
group, the mean FSIQ was greater than the FFD at all ages. Subtest analysis lent support
for the SCAD profile. Twenty-three percent of the ADHD subjects and none of the nonADHD group had Digit Span and Arithmetic as two of their three lowest subtest scores.
On the other hand, Kaufman (1994) argued that the SCAD profile added little
improvement to the ACID profile in terms of differential diagnosis; he suggested,
however, that comparing the SCAD profile with the subtests contributing to the Verbal
Comprehension and/ or Perceptual Reasoning Index could be useful in distinguishing
ADHD or LD students from non-ADHD children.
Although the performance profiles have provided useful information about the
cognitive performance of students with ADHD, they, too, have limited differential
diagnostic utility (Prifitera & Dersh, 1993; Schwean & Saklofske, 1998). Furthermore,
the profile analysis studies that have been discussed continue to be based on mean group
differences, which allows them to answer the question of whether or not group
membership is associated with reliable mean differences, but does not address questions
of classification or prediction (Assesmany et al., 2001). As a result, another approach has
been used by some researchers to address the question of whether or not a reliable,
differential diagnosis between groups of children with ADHD and children without
ADHD can be made from a child’s Wechsler scores (Ownby & Matthews, 1995; Stewart
& Moely, 1983; Wielkiewicz, 1990). This approach, known as discriminant function
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analysis, was designed to provide classification into groups, as well as an interpretation
of the dimensions underlying the differences in predictors (Assesmany et al., 2001).
Studies employing the WISC-R found that the Freedom from Distractibility factor (FFD)
did not discriminate children with ADHD from those without (Ownby & Matthews,
1995; Stewart & Moely, 1983; Wielkiewicz, 1990). Neither did studies utilizing the
WISC-III lend support for the use of the Freedom from Distractibility factor in
diagnosing ADHD (Prifitera & Dersh, 1993; Riccio, Cohen, Hall, & Ross, 1997). In
addition, analysis by Riccio and colleagues (1997) found that FFD does not correlate
significantly with other measures of attention or concentration and may perhaps be a
better measure of memory.
On the other hand, Assesmany and colleagues (2001) utilized discriminant
function analysis and found that the WISC-III has considerable discriminant validity for
ADHD diagnosis. Based on the results of their study, which included 80 children (40
with ADHD and 40 controls), they concluded that four WISC-III subtests contributed
significantly to the prediction of group membership. When these four subtests, which
included Digit Span, Information, Vocabulary, and Picture Completion, were used as
diagnostic predictors, 90% of children classified as ADHD and 87.5% of the non-ADHD
children were correctly identified. Of these subtests, the two best predictors were Digit
Span and Information. They suggested that Digit Span and Information subtest
performance could be useful in determining whether or not additional assessment should
be conducted to substantiate a diagnosis of ADHD.
The latest revision of the Wechsler Scales, the WISC-IV (Wechsler, 2000), puts
greater emphasis on working memory and processing speed, the subdomains that appear
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to be most highly affected by ADHD. Because such recent research has suggested that
the WISC-IV might adversely impact IQ scores of ADHD children (Barkley, 2000;
Mahone et al., 2003), Mahone and colleagues (2003) reported that reviews of the
Wechsler Scales for children indicate that individuals score, on average, 5 to 6 points
lower on the WISC-III (Wechsler, 1991) than on the WISC-R (Wechsler, 1974). These
differences were distributed disproportionately over subtests with larger discrepancies
found within the Performance Scale. Horn-Alsberge (1999) also found decreases in
performance between the WISC-R and WISC-III. Specifically, results found that
children with learning disabilities, ADHD, and affective disorders earned FSIQ’s
approximately 6 points lower on the WISC-III than the WISC-R. VIQ and PIQ were also
approximately 5 points lower on the WISC-III than the WISC-R. Based on these
findings, Mahone et al. (2003) cautioned that changes on reviewed subtests of the WISCIII Performance Scale may place children with ADHD at a disadvantage when compared
with their performances on the analogous WISC-R subtest. They hypothesized that the
increased executive demands associated with the WISC-III contributed to the lower FSIQ
scores. In addition, Barkley (2000) argued that the FFD subtests included in the WISCIII assess working memory and therefore may place children with ADHD at a
disadvantage.
In light of the research documenting weak processing speed and working memory
in individuals with ADHD, it is not all that surprising that decreases were found between
WISC-III and WISC-R scores. In general, the emphasis of these abilities on intelligence
tests has had a great impact on children diagnosed with ADHD. Schwean, Saklofske,
Yackulic and Quinn (1993) reported that, based on a discriminant validity study of the
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WISC-III and 45 ADHD children in which intercorrelations between subtests, index
scores and IQ scores were examined, patterns of correlations for the ADHD group were
similar to those reported for the WISC-III standardization sample across parallel age
groups. Furthermore, Prifitera, Saklofske, and Wiess (2005) describe the WISC-III as a
highly robust measure that retains its characteristics when used with individuals who
have ADHD. Given the fact that the WISC-IV maintains many of the same subtests and
a similar factor structure, Prifitera et al. (2005) contend that, in a manner similar to the
WISC-III, the WISC-IV will prove to be a psychometrically sound instrument applicable
for use in assessing ADHD children.
WISC-IV and ADHD
The WISC-IV continues to provide a reliable measure of global intelligence
(FSIQ); it has also enhanced the measure of more discrete domains of functioning (i.e.,
processing speed and working memory) and changed the dual IQ and index score
structure utilized in the WISC-III (J. Friedman, 2006). In addition to the FSIQ, the
WISC-IV yields four index scores (Verbal Comprehension Index (VCI), Perceptual
Reasoning Index (PRI), Processing Speed Index (PSI), and the Working Memory Index
(WMI)). The VCI is composed of the Similarities (SI), Comprehension (CO), and
Vocabulary (VO) subtests, which measure crystallized knowledge, verbal reasoning,
comprehension, and conceptualization. The Information (IN) and Word Reasoning (WR)
subtests are supplemental VC measures. The PRI is composed of the Block Design (BD),
Matrix Reasoning (MR), and Picture Concepts (PCN) subtests, which measure perceptual
reasoning and organization. A supplemental measure of perceptual reasoning, the Picture
Completion (PCM) subtest, is also available. The WMI is composed of the Digit Span
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(DS) and Letter Number Sequencing (LNS) subtests, which are purported to measure
attention, concentration, and working memory. The Arithmetic (AR) subtest is a
supplemental measure of working memory. Finally, the PSI is composed of the Coding
(CD) and Symbol Search (SS) subtests, which measure the speed of mental and
graphomotor processing. The Cancellation (CA) subtest, a supplemental measure of PS,
is also available on the WISC-IV.
The WISC-IV reflects the current status of intelligence theory, recognizing that
both global functioning and specific elements or abilities compose intelligence (J.
Friedman, 2006) . In addition, there is increased emphasis on working memory, which
reflects the perceived importance of this construct on learning and on overall cognitive
functioning. With the revisions of the WISC-IV, the working memory and processing
speed subtests now account for 4 of the 10 subtests included in the FSIQ calculations
versus 2 of the 10 subtests on the WISC-III. Because of the increased weight of working
memory and processing speed on the WISC-IV, the IQ scores of ADHD students could
be negatively impacted.
As part of its initial standardization, the WISC-IV was administered to 89
children ages 8 to 13 identified as having ADHD according to DSM-IV-TR diagnostic
criteria. The ADHD group included various subtypes (i.e., ADHD-IT, ADHD, HIT, and
ADHD-CT). Of the ADHD subjects, approximately 64% were treated pharmacologically
at the time of testing. Findings of the ADHD study included a moderate effect size for
group mean difference for the PSI and small effect sizes for the VCI, WMI, and FSIQ.
At the subtest level, the largest effect sizes for group mean differences occurred on the
Coding and Arithmetic subtests. There were only modest differences on other working
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memory and processing speed subtests. Small effect sizes for group mean score
differences occurred on Digit Span, Letter-Number Sequencing, Symbol Search, and
Cancellation.
Further analysis of the WISC-IV standardization study reveals, that relative to
their matched controls, ADHD children had slightly lower mean FSIQ scores (97.6
versus 102.7). Although these differences are statistically significant (p = .01), the effect
size (.38) is not large. These results support the previous studies that have found that
ADHD children typically achieve scores near the normative range of intellectual
functioning, but their performances may be worse on measures of processing speed and
working memory than on measures of verbal comprehension and perceptual reasoning
(Barkley, Murphy, & Bush, 2001; Doyle, Biederman, Seidman, Weber, & Faraone,
2000). Similar to findings with the WISC-III, children with ADHD who were
administered the WISC-IV obtained their lowest index score on the PSI and lowest
subtest score on Coding. ADHD children also performed lower than matched controls on
the WMI, with their lowest WMI subtest score on Arithmetic. The WISC-IV Technical
and Interpretive Manual (Wechsler, 2003) suggests that further research is needed to
examine separate samples of ADHD based on clinical subtype, as well as studies
comparing the performance of medicated versus nonmedicated ADHD children.
Although data exists regarding the medication status of the ADHD sample utilized, it was
not analyzed as part of the standardization study.
In 2006, Friedman conducted a study of the cognitive profiles of 109 students
with ADHD, utilizing WISC-IV data. These subjects were matched and compared with
non-ADHD controls. In keeping with the standardization data, Friedman did not find
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significant differences among FSIQ scores in ADHD samples versus non-ADHD
controls, but did find that the nonmedicated ADHD group performed significantly lower
than their non-ADHD controls on the WMI. Lowest WMI scores for the ADHD group
occurred on the Digit Span subtest. Unlike the WISC-IV standardization sample, no
significant differences were found on measures of processing speed. Based on her study,
Friedman indicated that further analysis is needed to look at VCI and WMI differences in
ADHD children, because her data suggested that statistical differences may be present.
Stimulant Medication
The impaired frontal lobe functioning and abnormalities in the dopamine
neurotransmitter system associated with ADHD (Preston, O'Neal, & Talaga, 2005) are
the reasons why dopamine agonists (i.e., stimulant medications) have been identified as
an efficacious intervention for reducing the symptoms of ADHD. In fact, medication is
perhaps the most common form of intervention for children with ADHD in the United
States. Of the 11 million prescriptions written for methylphenidate (Ritalin) each year,
approximately 80% are for children (Purdie et al., 2002). Given the number of children
with ADHD who receive psychopharmacological treatment, the effects of stimulant
medication on various aspects of functioning are relevant to many clinicians and
educators.
Additional support for the use of stimulant medications for ADHD comes from
numerous research studies, the majority of which have found that stimulants are highly
effective in treating both the executive and the behavior deficits of ADHD (Hale &
Fiorello, 2004). In 1992, Thomson examined the responses of children with ADHD to
stimulant medication. Overall, she found that measures of inattention and overactivity
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are the best predictors of responses to a stimulant medication as determined by parent and
teacher rating scales. Campbell (1991) examined the differences in cognitive and
affective characteristics relative to responses to stimulant medication. Two groups (one
with ADHD and one with undifferentiated ADD) were compared in a pre-test-post-test
design. Baseline measures included IQ, impulsivity, problem behavior, self-reported
depression, and self-esteem. After three months, medication response was measured. No
significant differences were found between groups for IQ, impulsivity, depression, selfesteem, anxiety, peer relationships, and social withdrawal. The stimulant medication did
decrease the hyperactive behaviors for the ADHD group. An improvement in the peer
relationships and aggressive behaviors in the ADD group was seen as a result of the
medication; however, these same benefits were not observed in the ADHD group.
Additional studies by Pelham and Milich (1991) and DuPaul, Barkley, and McMurray
(1994) have also found positive effects of stimulant medication on hyperactivity,
attention, concentration, and classroom behavior.
Also important to note is the Multimodal Treatment Study of Children with
ADHD (The MTA Cooperative Group, 1999). This study measured medication effects
on ADHD symptomatology, representing the largest study of this kind to date. This study
was a 14-month randomized clinical trial in which 579 children, aged 7 to 9.9 years who
had ADHD-CT, were assigned to various treatment modalities including medication
management, behavioral treatment, a combination of medication and behavioral
management or community-based treatment. Similar to the aforementioned studies, this
study found that students in the medication management or combined treatment group
demonstrated greater improvements in hyperactive-impulsive symptoms than those in the
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behavioral treatment alone or in community-based treatment groups. For other areas of
functioning, such as academic achievement, few differences among treatment groups
were found, except in the area of reading achievement assessed by the Wechsler
Individual Achievement Test. This study supported the robust, short-term efficacy of
medication management that has been found in other studies, and also extended these
findings by demonstrating that the benefits persisted for up to 14 months.
Stimulant Medication and Cognitive Performance. The effect of stimulant
medication on cognition and learning is less-well documented than the effect on behavior
and varies according to the measure and methodology utilized. Hale and colleagues
(1998) noted that a particular problem in the research literature is that many studies
include heterogeneous participants with different types of attention deficits, in addition to
ADHD group for analysis of MPH effects; this problem can obscure any robust results
for individual children.
Barkley (1998) noted that the impact of medication upon behavior and
concentration was most significant, but that performance on intelligence tests was less
affected by medication. Brown and Borden (1989) reported that stimulant medication
improves performance on rote or simple tasks, but that measures requiring the processing
of higher-order information may be less influenced. Furthermore, a study by Livingston
and colleagues (1996), in which the WISC-R and WISC-III scores for medicated and
nonmedicated children and adolescents were compared, did not find significant
differences in cognitive functioning between medicated and nonmedicated samples. Both
the medicated and nonmedicated groups performed poorly on the Freedom from
Distractibility Index, which included the Arithmetic, Digit Span and Coding subtests.
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Based on their findings, Livingston et al. (1996) concluded that although studies have
found that stimulant medication yields positive responses on overt ADHD
symptomatology and laboratory tests of cognitive performance, there is little evidence of
parallel long-term improvement on more traditional intellectual, neuropsychological, or
achievement measures. To explain this discrepancy between positive short-term effects
of psychostimulants on behavioral and cognitive functioning and lack of long-term
improvements, several hypotheses were made. First, they cite methodological limitations
such as lack of random assignment and intergroup differences as a possible confounding
variable. Psychostimulants have been found to enhance the functioning of subcortical
attention centers, but have limited impact on the information processing of cortical areas
(S. Goldstein & Goldstein, 1990). Because the measures used in this and many other
studies (Kagan, 2000; Saklofske, Schwean, & O'Donnell, 1996; Tannock, Martinussen, &
Frijters, 2000) primarily assess cortical functioning, they would not detect enhanced
subcortical functioning. One final hypothesis put forth by Livingston and colleagues is
related to the homeostatic down-regulation of receptors at different rates across brain
sites. Down-regulation is related to an inherent tendency to return to baseline or
homeostasis, which occurs through neuronal adaptations. Chronic exposure to high
levels of stress or certain medications causes a bombardment of certain excitatory
receptors, which often leads to a reduction in the number and density of excitatory
receptors, also known as down- regulation (Preston et al., 2005). Thus, after prolonged
use of psychostimulants, the neural systems responsible for short-term cognitive gains
may down- regulate; however, systems responsible for behavioral improvements may
have limited down- regulation (Livingston, Mears, Marshall, Gray, & Haak, 1996).

Cognitive Profiles of ADHD Students

37

Livingston and colleagues conclude that failure to document long-term improvement in
neurocognitive abilities is not taken as evidence against the efficacy of psychostimulant
medication for ADHD, but rather as evidence that ancillary interventions are also
warranted.
There is a need for further study of ADHD individuals, both pre- and postpharmacological intervention, in order to determine the impact of medication on test
sensitivity (Doyle et al., 2000). Some studies that have examined the short-term effects
of methylphenidate on the WISC-III have not revealed significant treatments effects for
subtest, factor, and index scores (Saklofske & Schwean, 1993; Schwean, Saklofske,
Yackulic, & Quinn, 1993). On the other hand, in 2003 Faraone reviewed the methods for
comparing medications across studies and provided examples, explaining how to apply
them to medicines utilized to treat ADHD. Using Cohen’s (1988) Standard Mean
Difference (SMD) to report efficacy in terms of continuous measurements, he calculated
effect sizes for stimulants and nonstimulants in the treatment of ADHD. In general, he
found greater effect sizes for stimulants than nonstimulants (.9 versus .6), with long
acting stimulants having slightly larger effect sizes on IQ (as measured by the Wechsler
scales). A small effect was defined as an increase in IQ of 3 points with the use of
medication; an increase in 7.5 IQ points was considered a medium effect, and an increase
of 12 points was considered a large effect size. Faraone found that the use of
nonstimulants increased IQ by 9 points; stimulants, both immediate release and longacting, increased IQ by 14 points.
Despite the large effect sizes for stimulant medication on intelligence tests found
in the Faraone study, the literature on long-term results of stimulant medication on
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cognitive functioning is relatively sparse. A long-term placebo-controlled study by
Gillberg and colleagues (1997) found positive effects of amphetamine treatment of
ADHD that remained 15 months after the start of treatment. This study included a
comparison between WISC-R scores of students who had been taking the placebo for 6
months or more, with those who had been taking the amphetamine for 9 months or more.
They found the mean change in IQ from 0 to 15 months for the group treated with
amphetamines for 9 or more months to be + 4.5 points (SD, 4.7), compared with + 0.7
(SD, 7.2) in the placebo group. As they had predicted, the amphetamine group
demonstrated a positive change in 28 of the 34 individuals, whereas in the placebo group
only 4 of 8 showed improvement.
Some studies have attempted to measure the effects of methylphenidate (MPH) on
specific areas of cognitive functioning known to be impacted by ADHD. These studies
have focused on the construct of working memory. Research in this area is conflicting;
some studies show that MPH improves both visual-spatial and auditory-verbal working
memory (i.e., Bedard et al., 2004; Mehta, Goodyer, & Shahakian, 2004; Tannock,
Ickowicz, & Schachar, 1995; Zeiner at al., 1999), but others have not (i.e., Rhodes,
Coghill, & Matthews, 2004; 2006). Most of these studies, however, measured only one
aspect of the four identified dimensions of working memory, utilizing only a single
measure. In order to gain a more comprehensive examination of the effects of MPH on
working memory, Bedard and colleagues (2007) focused on all four dimensions of
working memory. Specifically, they investigated both the modality (auditory-verbal or
visual-spatial) and processing (storage and manipulation) components of working
memory in school-aged children with ADHD. Major findings were that MPH had
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selective beneficial effects on working memory. Although it improved the ability to store
visual-spatial information, it did not impact auditory-verbal storage. MPH also improved
the ability to manipulate both visual-spatial and auditory-verbal information; however,
improvements were dependent upon the measure utilized to index working memory
manipulation. For example, MPH had a positive effect on visual-spatial manipulation on
the Finger Windows Backward subtest, but not on the Spatial Span Backward subtest.
MPH had a positive impact on the Letter Span Backward subtest, which was considered a
more effortful task, but not on the Digit Span Backward subtest.
Bedard and colleagues noted in their finding, that MPH has differential effects on
the storage of visual-spatial and auditory-verbal information is consistent with evidence
of lateralization of visual-spatial storage, attentional dysfunction in ADHD, and of MPH
effects. They linked their findings with those of Fletcher and Henson (2001), who
hypothesized that auditory-verbal storage tasks are left lateralized but that visual-spatial
are right lateralized in the brain. They further cited the evidence (i.e., Bellgrove et al.,
2005; Hermens et al., 2005; Sangal & Sangal, 2004) for left-sided inattention in ADHD
associated with right hemisphere dysfunction that responds well to MPH, stipulating that
MPH has selective effects on right neural networks supporting visual-spatial storage, but
not auditory-verbal storage. They note that additional research is needed using
neuroimaging and in examining different types of auditory-verbal and visual-spatial nonspan tasks which may recruit very different neural networks.
The WISC-IV standardization study did not analyze differences in ADHD
samples by treatment, although Prifitera and colleagues (2005) predicted that it would be
unlikely that WISC-IV performance would be affected by medication, considering the
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lack of treatment effects found with medication use in ADHD samples on WISC-III
performance. Schwean and Saklofske (2005), however, suggested that the WISC-IV has
considerable clinical value for monitoring cognitive changes of paramount importance in
determining the efficacy of medical, psychological, and educational programs.
In 2006, Friedman examined differences in FSIQ, Index scores, and Subtest
scores among medicated and nonmedicated ADHD samples and matched controls
selected from the WISC-IV normative sample. Friedman found no differences in overall
IQ between groups, but did find that the nonmedicated ADHD group had significantly
lower Working Memory Index scores than their matched controls. At the subtest level,
Digit Span scores were found to be significantly lower in the nonmedicated ADHD
sample than both the medicated ADHD group and non-ADHD controls.
Research Questions
The present study will replicate and expand on Friedman’s (2006) study which
examined mean differences between children with ADHD and non-ADHD controls on a
measure of cognitive functioning, as well as compared mean differences between
medicated ADHD students and non-medicated ADHD students. Friedman’s (2006) study
was an expansion of work completed during the standardization of the WISC-IV. In the
present study, Friedman’s hypotheses will be evaluated with the current data set. In
addition, Index score splits will be examined to determine whether or not ADHD students
display a significantly different cognitive profile from non-ADHD students. Although
Friedman’s (2006) comparison of Index and Subtest scores between the ADHD group
and non-ADHD group yielded significant differences that were limited to the Working
Memory Index and Digit Span subtest, it is possible that utilizing group means concealed
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some important intra-individual differences that could demonstrate diagnostic utility. In
addition, the current study will examine the Index score splits of individuals with ADHD
who are medicated, versus individuals with ADHD who are not medicated in an effort to
explore further the impact of medication on cognitive performance. Results of research
conducted to explore the effects of medication on cognitive performance are equivocal,
and thus further investigation in this area is needed. This information could have
implications both for the medical and for the educational treatment of ADHD.
Research Hypotheses
The first set of research hypotheses are designed to replicate Friedman’s (2006)
study. These research questions and hypotheses are as follows:
1. What is the impact of ADHD diagnosis on FSIQ scores of the WISC-IV?
a. It is predicted that results of this study will be consistent with results from
Friedman’s (2006) study, which did not find significant differences
between the mean FSIQ scores of the ADHD subjects and their nonADHD counterparts.
2. What is the impact of ADHD diagnosis of factor scores (VCI, PRI, WMI, and
PSI) of the WISC-IV?
a. In line with Friedman’s (2006) findings, it is predicted that there will be
no statistically significant differences between the ADHD groups and their
non-ADHD counterparts on the VCI, PRI, or PSI. It is predicted that there
will be a significant difference between the ADHD groups and nonADHD groups on the WMI. This difference is predicted to be more
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significant for the nonmedicated group of ADHD subjects than for the
non-ADHD groups and the medicated ADHD group.
3. How do ADHD individuals perform relative to non-ADHD individuals on each
subtest of the WISC-IV?
a. Consistent with Friedman’s (2006) finding, it is predicted that the mean
scores of ADHD students will be comparable with the mean scores of their
non-ADHD counterparts on the Verbal Reasoning subtests (VO, CO, SI),
Perceptual Reasoning subtests (BD, MR, and PCN), and Processing Speed
subtests (CD and SS). Some differences are expected between the ADHD
groups and their non-ADHD controls on the working memory subtests
(DS and LNS).
4. How does medication status impact WISC-IV FSIQ scores of students with
ADHD?
a. Consistent with Friedman’s (2006) findings, no differences are predicted
between the mean scores of the ADHD medicated group and the ADHD
nonmedicated group.
5. How does medication status impact ADHD students’ performance on the WISCIV Indices?
a. Friedman (2006) did not find any significant differences between the
medicated ADHD students and nonmedicated ADHD students for any of
the WISC-IV Indices. It is predicted that the current study will also
demonstrate comparable mean performances on the WISC-IV Indices
between the ADHD medicated and nonmedicated groups.
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6. How does medication status impact the performance of ADHD students on the
core subtests of the WISC-IV?
a. It is predicted that this study will replicate Friedman’s results.
Specifically, no significant differences are expected between the mean
subtests scores of the ADHD medicated and nonmedicated groups for any
of the 10 core subtests of the WISC-IV.
A second set of research questions specific to the current study will also be
investigated. The questions and hypotheses listed below are based on the reviewed
literature that overwhelmingly suggests that executive control deficits related to working
memory and processing speed are a core feature of ADHD and related to
neuropsychological factors.
7. How do individuals with ADHD perform on cognitive measures of working
memory relative to their performance on measures of other cognitive abilities?
This question will be explored by comparing the Working Memory Index and
Verbal Comprehension Index score splits between the ADHD groups and their
non-ADHD matched controls and by comparing the Working Memory Index and
General Ability Index score splits for the ADHD groups versus their non-ADHD
controls. The GAI is a sum of VCI and PRI scores and provides an overall
measure of reasoning abilities.
a. It is predicted that the ADHD groups will have a larger number of cases
with VCI scores greater than WMI scores relative to ADHD controls.

Cognitive Profiles of ADHD Students

44

b. It is also predicted that there will be a larger number of cases in the
ADHD groups with GAI scores greater than WMI scores, relative to nonADHD controls.
8. How do individuals with ADHD perform on cognitive measures of processing
speed, relative to their performance on measures of other cognitive abilities?
This question will be explored by comparing splits between Processing Speed
Index and Perceptual Reasoning Index scores in ADHD groups versus their nonADHD controls. The General Ability Index – Processing Speed Index score
splits will also be compared among groups.
a. It is predicted that there will be a greater number of cases in the ADHD
groups with PRI scores greater than PSI scores, relative to non-ADHD
controls.
b. It is also predicted that there will also be a larger number of cases in the
ADHD groups with PRI scores greater than PSI scores, relative to nonADHD controls.
In addition, this study seeks to find if there are differences in the cognitive
profiles of children with ADHD who are medicated versus those who are not. To evaluate
this, the following research questions and hypotheses will be studied.
9. To what extent does stimulant medication impact the working memory capacity
of ADHD children? This question will be explored by comparing the Working
Memory and Perceptual Reasoning Index score splits between the medicated
ADHD individuals and the non-medicated ADHD individuals. General Ability
Index and Working Memory score splits will also be compared among groups.
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a. It is predicted that the nonmedicated ADHD group will display more cases
of VCI scores greater than WMI scores, relative to the medicated ADHD
group.
b. It is predicted that the nonmedicated ADHD group will also display more
cases of GAI scores greater than WMI scores, relative to the medicated
ADHD group.
10. To what extent does stimulant medication impact processing speed in ADHD
children? This question will be explored by examining the Processing Speed
Index score versus measures of other cognitive abilities for medicated ADHD
individuals versus non-medicated ADHD individuals.
a. It is predicted that there will be a higher number of cases in the
nonmedicated ADHD group with PRI scores greater than PSI scores,
relative to the medicated ADHD group.
b. It is predicted that there will be a larger number of cases in the
nonmedicated ADHD group with GAI scores greater than PSI scores,
relative to the medicated ADHD group.
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Chapter 2
Method
Participants
The data utilized in the current study was archival in nature. Specifically, test
data archived in public school files were accessed to obtain the WISC-IV scores of 111
male students between the ages of 8 and 16, who had been diagnosed with ADHD by a
physician or psychologist, and had been tested as part of the school district’s educational
referral process. Archived public school data was obtained from a northeastern region of
the United States that included New Jersey, Pennsylvania, Delaware, Maryland, and
Connecticut. Data on students identified as having comorbid disabilities were not
systematically excluded from this study. In addition, students with all three subtypes of
ADHD (ADHD-IT, ADHD-HIT, and ADHD-CT) were included in the study.
The ADHD data was divided into two groups. The first group consisted of test
data from a group of 62 students not being treated pharmacologically for ADHD (i.e., the
nonmedicated group). In order to be assigned to this group, students met the following
criteria: (1) diagnosis of ADHD, (2) a WISC-IV Verbal Comprehension Index (VCI)
Standard Score greater than 80, and (3) indication that medication prescribed for the
symptoms of ADHD was not being taken at the time of the WISC-IV testing. The second
group consisted of test data from a group of 49 students who were being medicated for
ADHD at the time of assessment. Assignment to this group included the following
criteria: (1) diagnosis of ADHD, (2) a WISC-IV VCI Standard Score greater than 80, (3)
indication that medication prescribed for the symptoms of ADHD was being taken at the
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time of WISC-IV testing. Information regarding medication status was based on parent
report or information from the student’s file. Students taking stimulants, nonstimulants
or combinations of medication were included in this study.
In addition to the ADHD group, data was collected for a non-ADHD sample. This
non-ADHD sample was obtained from The Psychological Corporation’s WISC-IV
standardization sample. This non-ADHD group was divided into two groups. One group
consisted of 62 non-ADHD subjects matched as closely as possible with the ADHD nonmedicated group on the basis of chronological age, gender, ethnicity, parent education
level (when available), geographic region, and Verbal Comprehension Index. The second
group of 49 subjects was matched with the ADHD medicated group on the same
variables.
Confidentiality was assured by removing identifying information such as name
and date of birth. Only archived data were utilized. Information was collected using data
collection forms, which were secured in a locked file cabinet. Test scores and protocols
collected by the examiner were protected from unauthorized release and access. The
medicated and non-medicated groups were predetermined by parental choice; therefore,
the withholding of treatment was not an issue for this study. Test scores were interpreted
with consideration to contextual and cultural variables, as well as to the limitations of
current research and practice related to ADHD.
Variables
Independent Variables. The two independent variables included in this study
involve: ADHD diagnostic status (ADHD or non-ADHD) and treatment status (ADHD
medicated or ADHD nonmedicated).
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Dependent Variables. Dependent variables included the WISC-IV Index scores
(i.e., VCI, PRI, WMI, PSI, and FSIQ) and the differences or splits between factor scores
(i.e., VCI and WMI; GAI and WMI; PRI and PSI; GAI and PSI; VCI and PRI; and PSI
and WMI).
Overview of the Research Design
Participants were assigned to groups based on diagnosis and treatment status.
Mean scores for each of the WISC-IV FSIQ, Index scores, and subtest scores were
computed. General Ability Index (GAI) scores were also calculated for all groups. Mean
differences between WISC-IV Index scores (i.e., VCI and WMI; GAI and WMI; PRI and
PSI; GAI and PSI; VCI and PRI; and PSI and WMI) were then calculated for all groups
(ADHD medicated group; ADHD nonmedicated group; and the two non-ADHD matched
control groups) and were compared.
Measure and Procedure. School psychologists of selected schools were sent a
letter requesting participation in the study. Those who opted to participate received
permission from their school districts and signed letters of agreement. The school
psychologists were then asked to record WISC-IV test scores and demographic
information from ADHD students’ records on a data collection form. The information
requested on the data collection form included the following: raw and standard scores of
the 10 core WISC-IV subtests, as well as index scores; chronological age of the child;
gender; ethnicity; parent education level; diagnosis; treatment status; brand name of
medication; dosage and time of medication treatment; ADHD subtype; and additional
diagnoses. Raw scores were requested so that the accuracy of the reported standard
scores could be checked.
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The WISC-IV subtest and composite score data are considered interval data and
allow for the comparison of the four groups (medicated, nonmedicated, and two control
groups) among several variables (mean Index scores, mean Subtest scaled scores and
index score differences).
The WISC-IV, with over 60 years of research to support its practical and clinical
utility (Sattler, 2001), is considered a valid and reliable instrument with sufficient test
sensitivity to assess the constructs of working memory and processing speed. The
theoretical basis of the Wechsler Scales is further supported by its high correlation with
other measure of cognitive abilities, as well as by the appearance of similar subtests on
other measures of intelligence (Wechsler, 2003).
Statistical Analysis
Control groups were matched to the ADHD groups as closely as possible on
demographic variables of age, parent education level, ethnicity, and the Verbal
Comprehension Index so that there would be no significant differences on these variables
between the controls and their ADHD counterparts. It is noteworthy that parent
education level was not available for 47 of the ADHD cases.
The ADHD sample was divided into two groups. The first group consisted of the
students who were being treated pharmacologically for their ADHD symptoms
(medicated group) at the time of testing, and the second consisted of children who were
not being treated pharmacologically for ADHD (nonmedicated group). Two non-ADHD
control groups were then created by selecting samples from the archived WISC-IV
standardization data set obtained from the Psychological Corporation. The first nonADHD sample (Control 1) was matched with the ADHD medicated group, and the
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second non-ADHD sample (Control 2) was matched with the ADHD nonmedicated
group. Only subjects residing in the northeast or north central regions of the country
were utilized for the control groups.
Hypotheses Tests
To test the first hypotheses regarding mean FSIQ differences between ADHD
groups and non-ADHD groups, Univariate Analysis of Variance (ANOVA) was utilized.
ANOVA allows for the comparison of multiple groups on one dependent variable. To
test hypotheses relating to mean differences between WISC-IV Index scores and Subtest
scores, Multivariate Analysis of Variance (MANOVA) was utilized. MANOVA allows
for multiple groups to be compared among multiple dependent variables simultaneously
to minimize the Type I error that could result from conducting multiple tests of
significance among the dependent variables.
To test the second set of hypotheses involving the ADHD samples and their
matched controls, new variables representing Index score splits were calculated.
Cumulative percentages were then obtained for splits of 10, 15, 20, 25, 30 and 35 points
for the following: VCI > WMI; WMI > VCI; GAI > WMI; WMI > GAI; PRI > PSI; PSI
> PRI; GAI > PSI; PSI > GAI; VCI > PRI: PRI > VCI; PSI > WMI; and WMI > PSI.
The cumulative percentages were then utilized to calculate n values at each level in order
to use Fisher’s Exact Test to test the hypotheses. Fisher’s Exact Test allows for a
comparison of the proportions between groups. Fisher’s Exact Test is similar to ChiSquare. It calculates an exact probability value for the relationship between two
dichotomous variables. This statistic calculates the difference between the data expected
and the data observed, relative to the given marginal and assumptions of the model of
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independence. This statistic has advantages over the Chi-Square statistic, which gives
only an estimate of the true probability value, which may not be very accurate when the
marginal is uneven or should there be a small value in one of the cells (Uitenbroek,
1997). Specifically, Fisher’s Exact Test was utilized to compare the proportions of
subjects at each level of difference (10, 15, 20, 25, 30 and 35 points) for each of the Index
score splits between the ADHD groups and the non-ADHD groups. Fisher’s Exact Test
was calculated using Wang’s online significance test for comparing two proportions
(Wang, 1996).

Cognitive Profiles of ADHD Students

52

Chapter 3
Results
The results of the statistical tests described in Chapter 2 are presented in this
chapter, including the final composition of the sample, the statistical analysis utilized to
the test the hypotheses, and the results of the data analyses. Data was initially entered
into a Microsoft Excel spreadsheet and the exported to an SPSS file. Data were analyzed
using the Statistical Package for the Social Sciences (SPSS- 16.0). The significance level
for testing hypotheses was set at .05, although SPSS-16.0 reports significance at all
levels. As mentioned earlier, Wang’s (1996) online significance test for comparing two
proportions was utilized for the Fisher’s Exact Test calculations.
Demographic Information
The ADHD sample for this study consisted of 111 male students between the ages
of 8 and 16 who had been diagnosed with ADHD and tested with the WISC-IV as part of
a school district’s educational referral process. The first group consisted of 62 ADHD
male students who were not being medicated for their ADHD. The second group
consisted of 49 ADHD male students who were being medicated for their ADHD
symptoms. The brand name of the medication was available for 46 (94%) of the cases.
The largest proportion of cases took stimulant medications, with Concerta and Adderall
being the most frequently prescribed. The brand names of the ADHD medications were
as follows: 19 students were taking Concerta (29%); 9 students were taking Adderall
(14.5%); 4 students were taking Ritalin (6.5%); 4 students were taking Straterra (6.5%); 4
students were taking Focalin (6.5%) and 2 students took Daytrana (3.2%). Other less
common medications included Depakote, Abilify, Tegretol, Seroquel, and Risperdol.
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Four of the subjects were prescribed more than one medication (i.e., Focalin and Abilify;
Seroquel and Tegretol; Concerta and Depakote; and Straterra and Focalin). Only 14 of
the data forms included information regarding whether or not the medication was
immediate release or long-acting. Of those 14 cases, 5 were taking immediate release
medication, 8 were taking long-acting medications, and 1 was taking a combination of
both. The time of medication treatment was reported for 15 cases. Of these 15 cases, 12
took medication in the morning, 1 took medication in the afternoon, and 3 took
medication in both the morning and afternoon.
Two non-ADHD samples were then selected to serve as matched controls. These
samples were taken from the archived WISC-IV standardization data set that was
obtained from the Psychological Corporation. The non-ADHD sample consisted of 111
male students between the ages of 8 and 16, residing in the northeast regions of the
country. The non-ADHD sample was divided into two groups. The first group consisted
of 62 males and was matched to the nonmedicated ADHD group (Control 1). A second
group of 49 males was matched to the ADHD medicated group (Control 2). As
mentioned previously, the control groups were matched as closely as possible on the
basis of chronological age, gender, ethnicity, parent education level, and Verbal
Comprehension Index Standard Score.
The largest proportion both of the nonmedicated and of the medicated ADHD
groups were age 8. Over one- half of the children in both groups were age 10 or younger.
The controls were matched as closely as possible with their non-ADHD counterparts on
chronological age. Exact matches were not possible for a few subjects; this varied by one
to two years, at most. Table 1 provides the frequency distributions for chronological age
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in each of the four groups (ADHD Nonmedicated, Matched Control 1, ADHD
Medicated, and Matched Control 2).

Table 1
Frequency Distribution for Age
______________________________________________________________________
Age
____________________________________________________________________________
Group
8
9
10
11
12
13
14
15
16
____________________________________________________________________________
ADHD Nonmedicated
n

14.00

11.00

12.00

5.00

4.00

7.00

5.00

2.00

2.00

%
22.60 17.70 19.40 8.10
6.50
11.30 8.10
3.20
3.20
____________________________________________________________________________
Control 1a
n

14.00

11.00

11.00

5.00

4.00

8.00

4.00

3.00

2.00

%
22.60 17.70 17.70 8.10
6.50
12.90 6.50
4.80
3.20
____________________________________________________________________________
ADHD Medicated
n

13.00

5.00

10.00

3.00

3.00

4.00

6.00

3.00

2.00

%
26.50 10.20 20.40 6.10
6.10
8.20
12.20 6.10
4.10
____________________________________________________________________________
Control 2b
n

6.00

12.00

7.00

6.00

3.00

5.00

7.00

1.00

2.00

%
12.20 24.50 14.30 12.20 6.10
10.20 14.30 2.00
4.10
____________________________________________________________________________
Note. Age range from 8 to 16 years.
a

Control 1 = non-ADHD group matched to ADHD nonmedicated group

b

Control 2 = non-ADHD group matched to ADHD medicated group
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Parent Education Level ranged from 0-8 years up to a college or graduate degree.
Parent Education Levels were not reported for 47 of the ADHD cases; therefore, exact
matches could not be made and were estimated as best as they could possibly be. The
frequency distributions for Parent Education Level by group are provided in Table 2.

Table 2
Frequency Distribution for Parent Education Level
________________________________________________________________________
Parent Years of Education
______________________________________________________________________________________
Group
0-8
9-11
12
13-15
16+
______________________________________________________________________________________
ADHD Nonmedicated
n

0.00

2.00

16.00

8.00

9.00

%
0.00
3.20
25.80
12.90
14.50
_____________________________________________________________________________________
Control 1
n

2.00

6.00

24.00

15.00

15.00

%
3.20
9.70
38.70
24.20
24.20
_____________________________________________________________________________________
ADHD Medicated
n

0.00

2.00

9.00

5.00

13.00

%
0.00
4.10
18.40
10.20
26.50
_____________________________________________________________________________________
Control 2
n

1.00

4.00

12.00

14.00

18.00

%
2.00
8.20
24.50
28.60
36.70
_____________________________________________________________________________________
Note. 0-8 = eighth grade education or less; 9-11 = some high school; 12 years = high school or equivalent;
13-15 years = some college or associate degree; 16 or more years = college or graduate degree. Matched
Control 1 = ADHD nonmedicated control; matched Control 2 = ADHD medicated control.
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Parents of the nonmedicated ADHD children most frequently reported as having a
high school diploma (25.8%), but the medicated group most frequently reported having a
college or graduate degree (26.5%). Parent education levels were slightly higher among
the medicated group, with 36.7% with parent education levels falling in the some college
to college/ graduate degree range, and 26.4% of the nonmedicated group had parent
education levels in that range. The distributions reported for these groups appear similar
to those reported in the literature (NSCH, 2003).
The ADHD groups were also matched with controls on the basis of ethnicity.
Table 3 is a summary of the ethnicity for each of the four groups.
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Table 3
Frequency Distribution for Ethnicity
________________________________________________________________________
Ethnicity
______________________________________________________________________________
Group
White
Black
Hispanic
Other
______________________________________________________________________________
ADHD Nonmedicated
n

46.00

9.00

5.00

2.00

%
74.20
14.50
8.10
3.20
______________________________________________________________________________
Control 1
n

43.00

9.00

9.00

1.00

%
69.40
14.50
14.50
1.60
______________________________________________________________________________
ADHD Medicated
n

39.00

5.00

5.00

0.00

%
79.60
10.20
10.20
0.00
______________________________________________________________________________
Control 2
n

35.00

7.00

6.00

1.00

%

71.40

14.40

12.20

2.00

________________________________________________________________________

Finally, the ADHD groups were matched with controls by Verbal Comprehension
Index scores. VCI scores of the ADHD groups ranged from a low of 80 to a high of 155.
The ADHD children with VCI scores below 80 were not included in the study. VCI
means and standard deviations of the four groups are included in Table 4.
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Table 4
Verbal Comprehension Index Scores by Group
_________________________________________________________
Group

M

SD

ADHD Nonmedicated

96.37

11.72

Control 1

96.58

11.58

ADHD Medicated

101.71

14.92

Control 2

101.24

13.77

_________________________________________________________

Statistical Analysis
The control groups were matched with the ADHD groups on the demographic
factors of age, parent education levels, ethnicity, and the Verbal Comprehension Index, to
the degree that no significant differences were found among these variables between the
controls and their ADHD counterparts. Prior to statistical analysis, the Levene Statistic
was utilized to determine the extent to which the data met the assumptions required for
appropriate use of parametric inferential statistical tests of significance. The data did
meet the assumption of homogeneity of group variances for all study variables. No
significant differences were found among the variable variances of the ADHD groups and
matched controls, which allowed for the use of parametric inferential statistical
procedures.
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Hypotheses Tests
To test the hypotheses comparing the ADHD with non-ADHD controls and their
mean performances on different indices and subtests, three separate analyses were
utilized:
1. A one-way ANOVA investigated the differences among the mean FSIQ scores of
the medicated and nonmedicated ADHD groups, and the ADHD groups and their
matched controls.
2. A MANOVA was conducted to test the research question of whether or not there
were significant differences between the mean VCI, PRI, WMI, and PSI scores of
the medicated and nonmedicated ADHD groups and between the ADHD groups
and their matched controls.
3. A MANOVA was also conducted to test the research questions related to whether
or not there were significant differences between the medicated and nonmedicated
ADHD groups and the ADHD groups and their matched controls for each of the
10 WISC-IV core subtests (SI, CO, VC, BD, MR, PCn, DS, LNS, CD, and SS).
To test the second group of hypotheses related to whether or not students with
ADHD display weaknesses in working memory and processing speed, relative to their
other cognitive abilities, and also to whether or not the use of medication impacts
working memory and processing speed splits, the following procedures were utilized:
1. New variables were created to represent Index score splits. These variables
included: VCI-WMI difference, GAI-WMI difference, PRI-PSI difference, and
GAI-PSI difference.
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2. The cumulative percentage of subjects in each group with VCI-WMI, GAI-WMI,
PRI-PSI, and GAI-PSI splits of 10, -10, 15, -15, 20, -20, 25, -25, 30, -30, 35, and
-35 points was recorded.
3. N values were then calculated at each level for each group.
4. Fisher’s Exact Test was then utilized to analyze differences in proportions at each
level between the ADHD groups and their matched controls (i.e., nonmedicated
ADHD group and Control Group 1, and medicated ADHD group and Control
Group 2), and between the nonmedicated ADHD group and medicated ADHD
group.
Results of Hypotheses Tests
The FSIQ, Index, and Subtest means and standard deviations of the four groups
are listed in Tables 5 and 6.

Table 5
Index Mean Score by Group
________________________________________________________________________
Diagnostic Group
______________________________________________________________________________________
ADHD Non-Med
Index
Scores

(N=62)
________________
M
SD

Control 1

ADHD Med

(N=62)
______________
M
SD

(N=49)
________________
M
SD

Control 2
(N=49)
______________
M
SD

VCI

96.37

11.71

96.58

11.58

101.71

14.92

101.24

13.77

PRI

96.34

14.65

101.68

14.75

101.51

15.56

104.14

13.91

WMI

92.23

12.38

98.11

12.74

96.37

16.05

104.41

16.89

PSI

92.35

11.46

98.65

16.12

92.63

14.46

101.16

13.03

FSIQ

93.27

11.96

98.52

13.24

98.39

15.29

103.63

14.60
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Table 6
Subtest Scores by Group
________________________________________________________________________
Diagnostic Group
________________________________________________________________________
ADHD Non-Med

Control 1

ADHD Med

Index
(N=62)
(N=62)
Scores _________________ ______________
M
SD
M
SD

Control 2

(N=49)
(N=49)
______________ ________________
M
SD
M
SD

SI

10.06

2.70

9.32

2.72

11.06

3.08

10.55

2.64

VO

9.00

2.66

9.79

2.49

10.12

2.76

10.71

2.67

CO

9.13

2.29

9.19

2.42

9.94

2.98

9.61

2.78

BD

9.19

2.99

10.18

2.89

10.04

2.84

10.59

2.79

PCN

9.69

3.39

10.45

3.05

10.18

3.23

10.53

2.73

MR

9.03

3.31

10.16

2.89

10.45

3.04

10.84

3.09

DS

9.10

2.47

9.73

2.70

9.49

3.11

10.82

3.15

DSF

9.17

2.96

10.11

3.03

9.79

3.16

10.86

3.04

DSB

9.74

2.00

9.44

2.63

9.58

3.06

10.51

2.99

LNS

8.40

2.96

9.84

2.75

9.41

3.42

10.94

3.31

CD

8.32

2.76

9.63

3.10

8.08

2.57

9.57

2.52

SS

8.98

2.18

9.87

3.19

9.00

3.44

10.73

2.68
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Tests of Hypotheses 1 and 4. An ANOVA was utilized to evaluate whether or not
there were any significant differences between the mean FSIQ scores of any of the four
groups. The results of this test revealed that there were significant differences in mean
FSIQ scores between groups (F (3, 218) = 5.28, p = .002). See Table 7 for the ANOVA
results.

Table 7
Analysis of Variance for FSIQ
_______________________________________________________________________
SS
df
MS
F
Sig.
η2
_______________________________________________________________________
2957.950
3
985.983
5.280
0.002
0.067
_______________________________________________________________________

Given the fact that the results of the initial ANOVA revealed statistical
differences, post hoc analysis was conducted, utilizing Tukey’s Honestly Significant
Difference (Tukey HSD), with the significance level set at p < .05. Table 8 contains the
results of post hoc analysis.

Table 8
FSIQ Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

5.11

2.612

0.207

ADHD nonmed vs. Control 1

-5.24

2.454

0.145

ADHD med vs. Control 2

-5.24

2.761

0.231
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Post hoc results did not find any significant differences in mean FSIQ scores between the
medicated and nonmedicated ADHD groups; between the nonmedicated ADHD groups
and their matched controls, or between the medicated ADHD groups and their matched
controls. The only significant difference that did occur was between the nonmedicated
ADHD group and Control Group 2 (p = .002). Control Group 2 was the control group for
the medicated ADHD group and therefore this comparison is not meaningful to the
research questions of this study.
Tests of Hypotheses 2 and 5. Research questions 2 and 5, which were related to
the WISC-IV Index scores, were analyzed with a Multivariate Analysis of Variance
(MANOVA) to test multiple dependent variables (Index or Subtest scores)
simultaneously. The MANOVA was utilized to minimize the Type 1 error that could
result from conducting multiple tests of significance among the dependent variables.
Significant differences found during the Multivariate Analysis of Variance were
followed-up, using Tukey’s HSD, with the significance level set at p < .05.
Table 9 contains the results of the MANOVA conducted to test hypotheses 2 and
5 for group mean differences on the dependent variables, VCI, PRI, WMI, and PSI.
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Table 9
Multivariate Analysis for Index Scores
SS

Df

MS

F

Sig.

η2

VCI

1377.302

3

459.101

2.753

0.043*

0.037

PRI

1851.481

3

617.164

2.846

0.039*

0.038

WMI

4149.065

3

1383.022

6.655

0.000*

0.084

PSI

3116.486

3

1038.829

5.385

0.001*

0.069

Index
Scores

Note. Items with an asterisk are statistically significant.

The F tests of the group mean differences reveal significant differences between
groups on all WISC-IV Indices (VCI, PRI, WMI, and PSI). Although statistical
differences were found, the effect sizes were small for each factor.
The follow-up multiple comparisons of VCI, PRI, WMI, and PSI mean scores
among the four groups are shown in Tables 10, 11, 12, and 13.

Table 10
VCI Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

5.34

2.468

0.136

ADHD nonmed vs. Control 1

-2.1

2.319

1.000

ADHD med vs. Control 2

0.47

2.69

0.998
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Although the Multivariate Analysis of Variance was significant for VCI
differences, follow-up tests of significance, which were conducted to test pair-wise
comparisons among group means on the VCI, revealed no statistically significant
differences among the medicated and nonmedicated ADHD groups; among the
nonmedicated ADHD group and their matched controls, or among the medicated ADHD
group and their controls. Cross comparisons among non-related groups (i.e.,
nonmedicated ADHD group versus Control Group 2; medicated ADHD group versus
Control Group 1; and Control Group 1 and Control Group 2) also did not reveal
statistically significant differences.

Table 11
PRI Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

5.17

2.815

0.259

ADHD nonmed vs. Control 1

-5.34

2.645

0.184

ADHD med vs. Control 2

-2.63

2.975

0.813

Multivariate Analysis of Variance was significant for PRI mean differences
among groups; therefore, post hoc analyses were conducted to test pair-wise comparisons
among group means on the PRI. These analyses, using Tukey’s HSD revealed no
statistically significant differences among the medicated and nonmedicated ADHD
groups; among the nonmedicated ADHD group and their matched controls; or among the
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medicated ADHD group and their controls. The only statistically significant difference
that occurred was between the nonmedicated ADHD group and the matched controls for
the medicated ADHD group, a difference that is not relevant to the research questions
proposed in this study.

Table 12
WMI Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

4.14

2.755

0.437

ADHD nonmed vs. Control 1

-5.89

2.589

0.107

ADHD med vs. Control 2

-8.04

2.912

0.032*

Note. Items with an asterisk are statistically significant.

Follow-up multiple comparisons of WMI mean differences, using Tukey’s HSD
reveals a statistically significant difference between the ADHD medicated group and
their matched controls. There were no significant differences between the medicated and
nonmedicated ADHD groups and the nonmedicated ADHD group and their controls.
Cross comparisons among non-related groups (i.e., nonmedicated ADHD group versus
Control Group 2; medicated ADHD group versus Control Group 1, and Control Group 1
and Control Group 2) revealed statistical differences between the nonmedicated ADHD
group and Control Group 2.
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Table 13
PSI Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

0.28

2.655

1.000

ADHD nonmed vs. Control 1

-6.29

2.495

0.059

ADHD med vs. Control 2

-8.53

2.806

0.014*

Note. Items with an asterisk are statistically significant.

Post hoc tests of significance, using Tukey’s HSD revealed statistical differences
in mean PSI scores between the nonmedicated ADHD group and their matched controls
and between the medicated ADHD group and their controls. There was not a statistical
difference between the medicated and nonmedicated ADHD groups. Cross comparisons
among non-related groups (i.e., nonmedicated ADHD group versus Control Group 2;
medicated ADHD group versus Control Group 1, and Control Group 1 and Control
Group 2) revealed a statistical difference between the nonmedicated ADHD group and
Control Group 2.
Tests of Hypotheses 3 and 6. To test the hypotheses (3 and 6) involving
differences between groups on each of the 10 core WISC-IV subtests, a Multivariate
Analysis of Variance (MANOVA) was conducted to test the multiple dependant
variables. Significant differences found during the multivariate analysis of variance were
followed-up, using Tukey’s HSD, with the significance level set at p < .05. Results of
the MANOVA are included in Table 14.
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Table 14
Multivariate Analysis for Subtest Scores
SS

Df

MS

F

Sig.

η2

SI

91.199

3

30.400

3.939

0.009*

0.051

VO

85.253

3

28.416

4.088

0.008*

0.053

CO

23.392

3

7.797

1.154

0.328

0.016

BD

59.231

3

19.744

2.375

0.071

0.032

PCN

25.196

3

8.399

0.862

0.462

0.012

MR

103.100

3

34.367

3.603

0.014*

0.047

DS

85.497

3

28.499

3.531

0.016*

0.046

LNS

181.914

3

60.638

6.349

0.000*

0.080

CD

108.509

3

36.170

4.717

0.003*

0.061

SS

108.714

3

36.238

4.332

0.005*

0.056

Subtest
Scores

Note. Items with an asterisk are statistically significant.

The MANOVA revealed statistically significant differences between mean group
Subtest scaled scores on the SI, VO, MR, DS, LNS, CD and SS subtests. Although
statistical differences are found, effect sizes are again relatively small. Follow-up post
hoc analysis was conducted to evaluate further the nature of the statistically significant
differences. The results of these analyses are reported in Tables 15, 16, 17, 18, 19, 20,
and 21.
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Table 15
SI Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

1.00

0.531

0.241

ADHD nonmed vs. Control 1

0.74

0.499

0.447

ADHD med vs. Control 2

0.51

0.561

0.800

Although the MANOVA was significant for group differences in mean SI subtest
score, post hoc analysis did not reveal any significant differences between the medicated
ADHD and nonmedicated ADHD groups; the nonmedicated ADHD groups and their
matched controls, or between the medicated ADHD group and their matched controls.
The only significant difference in mean SI subtest score occurred between the medicated
ADHD group and Control Group 1, the control group matched to the nonmedicated
ADHD group (p = 0.007).

Table 16
VO Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

1.12

0.504

0.119

ADHD nonmed vs. Control 1

-0.79

0.474

0.343

ADHD med vs. Control 2

-0.59

0.533

0.683
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The MANOVA also revealed statistically significant differences in the mean VO
subtest score among groups. Therefore, post hoc analyses were conducted to explore
further the nature of these differences. Results of post hoc analysis, using Tukey’s HSD
did not reveal significant differences in mean VO subtest score between the medicated
and nonmedicated ADHD groups; between the nonmedicated ADHD group and their
matched controls, or between the ADHD medicated group and their matched controls.
The only significant difference occurred between the nonmedicated ADHD group and
Control Group 2, the matched controls for the medicated ADHD group, (p = 0.004).

Table 17
MR Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

1.42

0.590

0.080

ADHD nonmed vs. Control 1

-1.13

0.555

0.178

ADHD med vs. Control 2

-0.39

0.624

0.925

The MANOVA revealed statistical differences in the mean MR subtest score
among groups. Post hoc analyses were conducted to explore further the nature of these
differences. Results of Tukey’s HSD analysis did not reveal significant differences in
mean MR subtest score between the medicated and nonmedicated ADHD groups;
between the nonmedicated ADHD group and their matched controls, or between the
ADHD medicated group and their matched controls. The only significant difference
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occurred between the nonmedicated ADHD group and Control Group 2, the matched
controls for the medicated ADHD group (p = 0.013).

Table 18
DS Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

0.39

0.543

0.888

ADHD nonmed vs. Control 1

-0.63

0.510

0.607

ADHD med vs. Control 2

-1.33

0.574

0.099

The statistical differences in the mean DS subtest score among groups found in
the initial MANOVA were followed up with post hoc analyses using Tukey’s HSD.
Results of the post hoc analysis did not reveal statistical differences in mean DS subtest
score between the medicated and nonmedicated ADHD groups; between the
nonmedicated ADHD group and their matched controls, or between the ADHD
medicated group and their matched controls. The only significant difference occurred
between the nonmedicated ADHD group and Control Group 2 , which were the matched
controls for the medicated ADHD groups (p = 0.009).
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Table 19
LNS Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

1.00

0.591

0.326

ADHD nonmed vs. Control 1

-1.44

0.555

0.050*

ADHD med vs. Control 2

-1.53

0.624

0.071

Note. Items with an asterisk are statistically significant.

Statistically significant differences between groups related to mean LNS subtest
score were followed up with post hoc analysis, using Tukey’s HSD. Results of post hoc
analysis revealed statistical differences in mean LNS subtest scores between the
nonmedicated ADHD group and their matched controls. No statistically significant
differences occurred between the nonmedicated and medicated ADHD groups or between
the medicated ADHD group and their matched controls. One other statistical difference
occurred between the nonmedicated ADHD group and Control Group 2, the matched
controls for the medicated ADHD group (p < 0.01).
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Table 20
CD Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

-0.24

0.529

0.969

ADHD nonmed vs. Control 1

-1.31

0.497

0.045*

ADHD med vs. Control 2

-1.49

0.559

0.041*

Note. Items with an asterisk are statistically significant.

Statistically significant differences between groups for mean CD subtest score
found in the initial MANOVA were followed up with post hoc analysis to determine the
nature of the differences. Results of the post hoc analysis, using Tukey’s HSD revealed
statistically significant differences in mean CD subtest score between the nonmedicated
ADHD group and their matched controls and between the medicated ADHD group and
their matched controls. There was not a statistically significant difference in mean CD
subtest score between the medicated and nonmedicated ADHD groups. Other
statistically significant differences were found in a cross comparison of the medicated
ADHD group and Control Group 1, the matched controls for the nonmedicated ADHD
group (p = 0.02).
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Table 21
SS Mean Difference Comparisons

Group Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

0.02

0.553

1.000

ADHD nonmed vs. Control 1

-0.89

0.519

0.322

ADHD med vs. Control 2

-1.73

0.582

0.017*

Note. Items with an asterisk are statistically significant.

Statistical differences in mean SS subtest score identified from the initial
MANOVA were followed up with post hoc analysis to explore the nature of these
differences. Results of the post hoc analysis utilizing Tukey’s HSD revealed statistically
significant differences in mean SS subtest score between the medicated ADHD group and
their matched controls. There were no statistically significant differences between the
medicated and nonmedicated ADHD groups or between the nonmedicated ADHD group
and their matched controls. Cross comparisons also revealed statistically significant
differences in mean SS subtest scores between the nonmedicated ADHD group and
Control Group 2, the matched controls for the medicated ADHD group (p = 0.009).
A separate MANOVA was conducted to explore mean differences in DSF and
DSB subtest scaled score between groups. This analysis was conducted separately
because these scores were not available for each subject, as the other subtest scores were.
DSF and DSB scores were available for 42 of the 62 nonmedicated ADHD subjects and
for 33 of the 49 medicated ADHD subjects. DSF and DSB scores were available for all
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62 subjects in Control Group 1 and for all 49 subjects in Control Group 2. The results of
the MANOVA are presented in Table 22.

Table 22
Multivariate Analysis for DSF and DSB Scores
SS

Df

MS

F

Sig.

η2

DSF

67.178

3

22.393

2.427

0.067

0.038

DSB

34.747

3

11.582

1.600

0.191

0.026

Subtest
Scores

There were no statistically significant differences in mean scaled scores on the DSF and
DSB subtests between groups in this study.
Tests of Hypotheses 7 and 8. To test the research questions and hypotheses
regarding ADHD diagnosis and Index score splits, the following variables were
calculated for each subject: VCI-WMI differences; GAI-WMI differences; PRI-PSI
differences, and GAI-PSI differences. Cumulative percentages were then obtained for
differences at the following magnitudes: 10 points, 15 points, 20 points, 25 points, 30
points, 35 points, -10 points, -15 points, -20 points, -25 points, -30 points, and -35 points.
Cumulative percentages were then converted to n values. The n values were then utilized
to compare the significance between proportions, using Fisher’s Exact Test. The z values
and significance levels of these analyses are reported in Tables 23 though 30.
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Table 23.1
Frequency of VCI > WMI by Group
________________________________________________________________________
Diagnostic Group
ADHD Non-Med
(N=62)

Control 1
(N=62)

ADHD Med
(N=49)

Control 2
(N=49)

______________

_______________

_____________

___________

10 points

23

13

22

7

15 points

12

7

12

5

20 points

7

4

6

3

25 points

2

1

2

2

30 points

2

1

1

0

35 points

1

1

0

0

Index Score
Differences

Table 23.2
Fisher’s Exact Test for VCI > WMI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index Score
Differences

z value

p value

Medicated ADHD vs. Control 2
(n = 49)
z value

p value

____________ ________________ _______________ __________________
10

1.978

0.024*

3.320

0.001*

15

1.247

0.106

1.867

0.031*

20

1.215

0.112

1.049

0.147

25

1.017

0.155

0.000

0.500

30

1.017

0.155

1.005

0.157

35

0.585

0.280

--

--

Note. Items with an asterisk are statistically significant.
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The frequency of subjects evidencing greater VCI than WMI scores tended to be
greater for the ADHD groups than for their matched controls at all levels. To test the
significance of these frequency differences, Fisher’s Exact Test was utilized to compare
the proportion of subjects in each group who evidenced VCI scores greater than WMI
scores at each level of difference (i.e., 10, 15, 20, 25, 30 and 35). The results of these
calculations reveal significantly more 10 point splits in the nonmedicated ADHD group
than in Control Group 1. Specifically 37.1% (n = 23) of the nonmedicated ADHD group
evidenced 10 point VCI-WMI splits, but 21% (n = 13) of Control Group 1 evidenced 10
point VCI-WMI splits. Significantly more 10 and 15 point VCI-WMI splits were found
in the medicated ADHD group (10 point split = 44.9%; 15 point split = 24.5%) than in
Control Group 2 (10 point split = 14.3%; 15 point split = 10.2%).

Table 24.1
Frequency of WMI > VCI by Group
________________________________________________________________________
Diagnostic Group

Index Score
Differences

ADHD NonControl 1
Med
(N=62)
(N=62)
______________ _______________

ADHD
Med
(N=49)
_________

Control 2
(N=49)
________________

10 points

13

20

8

17

15 points

8

9

4

10

20 points

2

3

3

7

25 points

0

2

0

2

30 points

0

2

0

1

35 points

0

0

0

1
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Table 24.2
Fisher’s Exact Test for WMI > VCI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index
Score
Differences

z value

p value

Medicated ADHD vs. Control 2
(n = 49)
z value

________________ ________________ _____________

p value
________________

10

-1.422

0.078

-2.086

0.019*

15

0.000

0.500

-1.732

0.042*

20

0.000

0.500

-1.335

0.091

25

-1.426

0.077

-1.429

0.077

30

-1.426

0.077

-1.005

0.157

35

--

--

-1.005

0.157

Note. Items with an asterisk are statistically significant.

The frequency of subjects with WMI scores greater than VCI scores tended to be
greater for the non-ADHD controls than for the ADHD groups at all levels. Fisher’s
Exact Test was utilized to determine the significance of these differences in frequencies
across groups. These calculations indicated that there were significantly more 10 and 15
point splits in Control Group 2 than in their ADHD counterparts (medicated ADHD
group). Slightly more than twice as many subjects in Control Group 2 evidenced 10
(34.7%) and 15 (20.4%) point WMI-VCI splits than in the medicated ADHD group (10
point split = 16.3%; 15 point splits = 8.2%). There were no significant differences
between the nonmedicated ADHD group and their matched controls.
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Table 25.1
Frequency of GAI > WMI by Group
________________________________________________________________________
Diagnostic Group

Index Score
Differences

ADHD Non-Med
(N=62)
______________

Control 1
(N=62)

ADHD Med
(N=49)

Control 2
(N=49)

_____________

_____________

_______________

10 points

24

20

23

12

15 points

13

11

9

8

20 points

9

7

5

3

25 points

5

0

2

2

30 points

4

0

0

0

35 points

2

0

0

0

Table 25.2
Fisher’s Exact Test GAI > WMI
Nonmedicated ADHD vs. Control 1
(n = 62)

Medicated ADHD vs. Control 2
(n = 49)

Index Score
Differences

z value
_____________

p value
z value
________________ _______________

10

0.751

0.226

2.319

0.010*

15

0.455

0.325

0.267

0.395

20

0.536

0.296

0.738

0.230

25

2.283

0.011*

0.000

0.500

30

2.033

0.021*

--

--

35

1.426

0.077

--

--

Note. Items with an asterisk are statistically significant.

p value
______________
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The frequency of cases evidencing GAI scores greater than WMI scores was
greater in the ADHD groups, compared with their matched controls at almost all levels.
To determine the significance of the differences in frequencies among groups, Fisher’s
Exact Test was utilized to compare the proportion of subjects in each group evidencing
GAI scores greater than the WMI scores. Comparisons revealed that there were
significantly more subjects in the nonmedicated ADHD group with GAI-WMI splits of
25 (8.1%) and 30 (6.5%) points than in Control Group 1, which had no instances of 25 or
30 point splits. Almost twice as many medicated ADHD subjects had GAI-WMI splits of
10 points (46.9%) than subjects in Control Group 2 (24.5%).

Table 26.1
Frequency of WMI > GAI by Group
________________________________________________________________________
Diagnostic Group
ADHD NonMed
(N=62)
______________

Control 1
(N=62)

ADHD Med
(N=49)

Control 2
(N=49)

_____________

______________

_____________

10 points

13

16

6

12

15 points

7

5

1

6

20 points

5

3

0

3

25 points

2

1

0

1

30 points

0

0

0

0

35 points

0

0

0

0

Index Score
Differences
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Table 26.2
Fisher’s Exact Test WMI >GAI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
p value
________________ ________________ _______________ ______________

10

-0.637

0.262

-1.565

0.059

15

0.608

0.728

-1.961

0.025*

20

0.731

0.768

-1.759

0.039*

25

0.585

0.721

-1.005

0.157

30

--

--

--

--

35

--

--

--

--

Note. Items with an asterisk are statistically significant.

Comparing the frequency of cases between groups with WMI scores greater than
GAI was not as consistent. There was no predictable pattern between the nonmedicated
ADHD group and their controls. On the other hand, the ADHD medicated group tended
to evidence lower frequencies when compared with their matched controls. To determine
the significance of the differences in frequency, Fisher’s Exact Test was utilized to
compare proportions of subjects with WMI scores greater than GAI scores. These
calculations reveal that significantly more 10 and 15 point differences occurred in
Control Group 2 compared with the medicated ADHD group. Specifically,
approximately twice as many controls evidenced 10 (34.7% vs. 16.3%) and 15 (20.4% vs.
8.2%) point splits when compared to their medicated ADHD counterparts. There were
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no significant differences between the nonmedicated ADHD group and their matched
controls.

Table 27.1
Frequency of PRI >PSI by Group
________________________________________________________________________
Diagnostic Group
ADHD NonMed
(N=62)
______________

Control 1
(N=62)

ADHD Med
(N=49)

Control 2
(N=49)

____________

_____________

____________

10 points

20

21

24

16

15 points

14

18

21

10

20 points

11

10

14

6

25 points

7

6

6

4

30 points

4

3

4

1

35 points

3

2

4

1

Index Score
Differences
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Table 27.2
Fisher’s Exact Test PRI > PSI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
p value
________________ ________________ _______________ ______________

10

-0.191

0.576

1.644

0.050

15

-0.821

0.794

2.389

0.008*

20

0.239

0.405

2.005

0.023*

25

0.293

0.384

0.667

0.252

30

0.389

0.349

1.377

0.084

35

0.457

0.324

1.377

0.084

Note. Items with an asterisk are statistically significant.

The frequency of cases evidencing greater PRI scores than PSI scores was
generally higher for the ADHD groups than for their controls. The results of Fisher’s
Exact Test revealed that significantly more medicated ADHD subjects evidenced 15 and
20 point PRI-PSI splits than their matched controls. Specifically, over two times as many
medicated ADHD subjects evidenced 15 points splits (42.9%) than their matched controls
(20.4%). Over twice as many medicated ADHD subjects also evidenced 20 point PRIPSI splits (28.6%) compared with their non-ADHD counterparts (12.2%). There were no
statistically significant differences between the nonmedicated ADHD group and their
matched controls.
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Table 28.1
Frequency of PSI > PRI by Group
________________________________________________________________________
Diagnostic Group

Index Score
Differences

10 points

ADHD Non-Med
(N=62)
_____________
_
9

Control 1
(N=62)

ADHD Med
(N=49)

Control 2
(N=49)

____________

_____________

________________

15

6

10

15 points

6

9

6

6

20 points

4

6

3

3

25 points

2

2

3

3

30 points

0

2

2

0

35 points

0

1

0

0

Table 28.2
Fisher’s Exact Test PSI > PRI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
p value
________________ ________________ _______________ ______________

10

-1.364

0.086

-1.093

0.137

15

-0.826

0.204

0.000

0.500

20

-0.660

0.255

0.000

0.500

25

0.000

0.500

0.000

0.500

30

-1.426

0.077

1.429

0.924

35

-1.004

0.158

--

--
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The frequency of cases in Control Group 1who evidenced stronger PSI than PRI
scores tended to be slightly greater than in their ADHD counterparts (nonmedicated
ADHD group); however, the frequency of cases with stronger PSI scores was fairly
similar between the medicated ADHD group and their controls. Z values were computed
to determine whether or not any statistically significant differences occurred between
groups. The results of this computation did not yield any significant differences between
the proportions of cases with PSI scores greater than PRI scores in each group.

Table 29.1
Frequency of GAI > PSI by Group
________________________________________________________________________
Diagnostic Group
ADHD Non-Med
(N=62)
______________

Control 1
(N=62)
__________

ADHD Med
(N=49)
_________

Control 2
(N=49)
_____________

10 points

21

18

25

14

15 points

13

12

16

9

20 points

10

6

15

7

25 points

7

4

12

4

30 points

3

3

4

2

35 points

2

1

3

1

Index Score
Differences
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Table 29.2
Fisher’s Exact Test GAI > PSI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
p value
________________ ________________ _______________ ______________

10

0.580

0.281

2.270

0.012*

15

0.224

0.411

1.622

0.052

20

1.072

0.142

1.937

0.026*

25

0.948

0.172

2.186

0.014*

30

0.000

0.500

0.843

0.200

35

0.585

0.280

1.021

0.154

Note. Items with an asterisk are statistically significant.

The frequency of cases with GAI scores greater than PSI scores was higher for the
ADHD groups at all levels than for their matched controls. The significance of
differences in proportions between groups was tested by calculating z values, using
Fisher’s Exact Test. These calculations found statistically significant differences
between the medicated ADHD group and their matched controls at the 10, 20 and 25
point levels. Just over twice as many medicated ADHD subjects (30.6%) as subjects in
Control Group 2 (14.3%) evidenced 20 point GAI-PSI splits. Three times as many
medicated ADHD subjects (24.5%) evidenced 25 point splits when compared with
Control Group 2 (8.2%). There were no statistically significant differences between the
nonmedicated ADHD group and their controls.

Cognitive Profiles of ADHD Students

87

Table 30.1
Frequency of PSI > GAI by Group
________________________________________________________________________
Diagnostic Group
ADHD Non-Med
(N=62)
______________

Control 1
(N=62)
____________

ADHD Med
(N=49)
__________

Control 2
(N=49)
__________

10 points

10

15

6

9

15 points

7

11

4

6

20 points

4

8

3

4

25 points

3

3

2

3

30 points

0

2

0

3

35 points

0

0

0

1

Index Score
Differences

Table 30.2
Fisher’s Exact Test PSI > GAI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
p value
________________ ________________ _______________ ______________

10

-1.119

0.132

-0.842

0.200

15

-1.020

0.154

-0.667

0.252

20

-1.214

0.112

-0.392

0.347

25

0.000

0.500

-0.459

0.323

30

-1.426

0.077

-1.759

0.039*

35

--

--

-1.005

0.157

Note. Items with an asterisk are statistically significant.
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The frequency of cases with PSI scores greater than GAI scores tended to be
greater at all levels for the controls than for the ADHD groups. To compare the
significance of differences in the proportions among groups, Fisher’s Exact Test was
utilized. These calculations revealed that significantly more controls (6.1%) evidenced
30 point PSI-GAI differences than their medicated ADHD counterparts (n = 0).
Comparisons of Other Factor Scores. Statistical analysis was also conducted to
evaluate splits between other factor scores. Specifically, VCI-PRI splits and WMI-PSI
splits were examined. Given the fact that that no differences were predicted, the Fisher’s
Exact Test evaluated the null hypothesis utilizing a two-sided z-test. Tables 31 and 32
contain the frequencies and results of Fisher’s Exact Test.

Table 31.1
Frequency of VCI > PRI by Group
________________________________________________________________________
Diagnostic Group
ADHD Non-Med
(N=62)
______________

Control 1
(N=62)
___________

ADHD Med
(N=49)
_________

Control 2
(N=49)
____________

10 points

8

8

10

6

15 points

4

5

8

2

20 points

1

4

3

0

25 points

1

2

2

0

30 points

0

1

2

0

35 points

0

0

0

0

Index Score
Differences
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Table 31.2
Fisher’s Exact Test VCI >PRI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index
Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
________________ ________________ _______________

p value
______________

10

0.000

1.000

1.093

0.274

15

0.346

0.729

2.002

0.045*

20

1.370

0.171

1.759

0.079

25

0.584

0.559

1.429

0.153

30

1.004

0.315

1.429

0.153

35

--

--

--

--

Note. Items with an asterisk are statistically significant.

The proportions of nonmedicated ADHD subjects and subjects in the matched
control group with VCI scores greater than PRI scores were similar at all levels. The
proportion of medicated ADHD subjects with VCI scores greater than PRI scores was
significantly greater than their matched controls at the 15 point level. Approximately
four times the number of medicated ADHD subjects had VCI-PRI splits of 15 points
when compared with their matched controls (16.3% versus 4.1%).
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Table 31.3
Frequency of PRI > VCI by Group
________________________________________________________________________
Diagnostic Group
ADHD NonMed
(N=62)
__________

Control 1
(N=62)

ADHD Med
(N=49)

Control 2
(N=49)

_______________

________

___________

10 points

8

23

11

11

15 points

4

18

7

7

20 points

1

7

5

4

25 points

1

3

3

3

30 points

0

0

1

3

35 points

0

0

0

1

Index Score
Differences

Table 31.4
Fisher’s Exact Test PRI >VCI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index
Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
________________ ________________ _______________

p value
______________

10

3.111

0.002*

0.000

1.000

15

3.291

0.001*

0.000

1.000

20

2.193

0.029*

0.350

0.727

25

1.017

0.309

0.000

1.000

30

--

--

1.021

0.307

35

--

--

1.005

0.315

Note. Items with an asterisk are statistically significant.
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The proportion of subjects in Control Group 1with PRI scores 10, 15 and 20
points greater than their VCI scores was significantly greater than the proportion of
subjects from the nonmedicated ADHD group with these differences. Specifically,
37.1% of Control Group 1 had PRI score greater than VCI scores by 10 points, but only
12.9% of the nonmedicated ADHD group did. Of Control Group 1, 29% also displayed
PRI scores greater than VCI scores by 15 points, but 6.5% of the nonmedicated ADHD
group displayed this level of difference. Finally, 11.3% of Control Group 1 displayed
PRI scores 20 points greater than VCI scores, compared with 1.6% of the nonmedicated
ADHD group. There were no statistically significant differences between the medicated
ADHD group and their matched controls.

Table 32.1
Frequency of WMI > PSI by Group
________________________________________________________________________
Diagnostic Group
ADHD Non-Med
(N=62)
______________

Control 1
(N=62)
___________

ADHD Med
(N=49)
__________

Control 2
(N=49)
___________

10 points

20

17

20

18

15 points

8

10

13

9

20 points

3

5

9

6

25 points

0

3

7

5

30 points

0

2

3

2

35 points

0

1

3

2

Index Score
Differences
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Table 32.2
Fisher’s Exact Test WMI >PSI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index
Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
________________ ________________ _______________

p value
______________

10

0.589

0.556

0.415

0.678

15

0.510

0.610

0.968

0.333

20

0.731

0.465

0.842

0.400

25

1.753

0.080

0.616

0.538

30

1.426

0.154

0.459

0.646

35

1.004

0.315

0.459

0.646

Comparisons were also made between the WMI and PSI. The proportion of
nonmedicated ADHD subjects and subjects in Control Group 1with WMI scores greater
than PSI scores was comparable at all levels. Similarly, the proportion of medicated
ADHD subjects and subjects in Control Group 2 with WMI scores greater than PSI
scores was comparable at all levels.
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Table 32.3
Frequency of PSI > WMI by Group
________________________________________________________________________
Diagnostic Group
ADHD Non-Med
(N=62)
______________

Control 1
(N=62)
__________

ADHD Med
(N=49)
__________

Control 2
(N=49)
____________

10 points

17

16

12

14

15 points

8

13

9

10

20 points

6

9

5

2

25 points

4

5

4

1

30 points

2

1

2

0

35 points

1

1

1

0

Index Score
Differences

Table 32.4
Fisher’s Exact Test PSI >WMI
Nonmedicated ADHD vs. Control 1
(n = 62)
Index
Score
Differences

Medicated ADHD vs. Control 2
(n = 49)

z value
p value
z value
________________ ________________ _______________

p value
______________

10

0.203

0.839

0.458

0.647

15

1.197

0.231

0.256

0.798

20

0.826

0.409

1.177

0.239

25

0.346

0.729

1.377

0.168

30

0.585

0.559

1.429

0.153

35

0.000

1.000

1.005

0.315
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The proportion of nonmedicated ADHD subjects and subjects in Control Group
1with PSI scores greater than WMI scores was comparable at all levels. Similarly, the
proportion of medicated ADHD subjects and subjects in Control Group 2 with PSI scores
greater than WMI scores was comparable at all levels.
Tests of Hypotheses 9 and 10. To test the research questions and hypotheses
regarding the impact of medication status on working memory and processing speed,
comparisons were made among VCI-WMI, GAI-WMI, PRI-PSI, and GAI-PSI Index
scores splits between the nonmedicated and medicated ADHD groups. Similar to the
tests for hypotheses 7 and 8, cumulative percentages and n values were obtained for
differences at the following magnitudes: 10 points, 15 points, 20 points, 25 points, 30
points, 35 points, -10 points, -15 points, -20 points, -25 points, -30 points, and -35 points.
The n values were then utilized to compute Fisher’s Exact Test to compare the
significance between proportions. Tables 33 through 40 contain the z values and
significance levels for these comparisons.

Cognitive Profiles of ADHD Students
Table 33
Fisher’s Exact Test VCI > WMI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences
z value

p value

10 points

-0.831

0.797

15 points

-0.653

0.743

20 points

0.104

0.458

25 points

0.191

0.424

30 points

0.785

0.216

35 points

0.382

0.351

Note. Items with an asterisk are statistically significant.

Table 34
Fisher’s Exact Test WMI > VCI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences
z value

p value

10 points

0.620

0.732

15 points

1.034

0.849

20 points

-0.297

0.383

25 points

--

--

30 points

--

--

35 points

--

--
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The frequency of subjects evidencing VCI and WMI splits in either direction was
similar across ADHD groups.

Table 35
Fisher’s Exact Test GAI > WMI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences

z value

p value

10 points

-0.871

0.808

15 points

0.341

0.366

20 points

0.680

0.248

25 points

0.857

0.195

30 points

1.811

0.035*

35 points

1.269

0.102

Table 36
Fisher’s Exact Test WMI > GAI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences

z value

p value

10 points

1.212

0.887

15 points

1.871

0.969

20 points

2.034

0.979

25 points

1.269

0.897

30 points

--

--

35 points

--

--
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The frequency of cases evidencing GAI scores greater than WMI scores was
slightly greater in the nonmedicated ADHD group than in the medicated ADHD group.
To determine the significance of the differences in frequencies among groups, Fisher’s
Exact Test was utilized to compare the proportion of subjects. Comparisons revealed
that there were significantly more subjects in the nonmedicated ADHD group with GAIWMI splits of 30 points (6.5%, n = 4) than in the medicated ADHD group (n = 0).
The frequency of cases with WMI scores greater than GAI scores was slightly
higher in the nonmedicated ADHD group than in the medicated ADHD. Fisher’s Exact
Test revealed no statistically significant differences.

Table 37
Fisher’s Exact Test PRI > PSI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences

z value

p value

10 points

-1.788

0.963

15 points

-2.283

0.988

20 points

-1.356

0.912

25 points

-0.155

0.561

30 points

-0.346

0.635

35 points

-0.716

0.762
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Table 38
Fisher’s Exact Test PSI >PRI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences

z value

p value

10 points

0.348

0.635

15 points

-0.433

0.332

20 points

0.071

0.528

25 points

-0.731

0.528

30 points

-1.601

0.054

35 points

--

--

The frequency of cases evidencing greater PRI scores than PSI scores was slightly
higher for the medicated ADHD group than for the nonmedicated ADHD group, opposite
of what was predicted. Therefore, Fisher’s Exact Test calculations did not reveal any
statistically significant findings, utilizing the assumptions of the research hypothesis. If
the Fisher’s Exact Test is run with the opposite hypothesis, the medicated ADHD group
actually displays significantly larger proportions of students with PRI scores at least 10
points (p = 0.037) or 15 points (p = 0.011) larger than PSI, relative to the nonmedicated
ADHD group.
The frequency of cases with PSI scores greater than PRI scores was fairly similar
across the nonmedicated and medicated ADHD groups. No statistically significant
differences were found.
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Table 39
Fisher’s Exact Test GAI > PSI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences

z value

p value

10 points

-1.821

0.965

15 points

-1.392

0.918

20 points

-1.814

0.965

25 points

-1.833

0.966

30 points

-0.716

0.762

35 points

-0.731

0.767

Table 40
Fisher’s Exact Test PSI > GAI
Nonmedicated vs. Medicated
(n = 62; n = 49)
Index Score
Differences

z value

p value

10 points

0.579

0.718

15 points

0.548

0.708

20 points

0.071

0.528

25 points

0.191

0.575

30 points

--

--

35 points

--

--
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The frequency of cases with GAI scores greater than PSI scores was slightly
higher for the medicated ADHD group than for the nonmedicated ADHD group, which
was opposite of the finding predicted. Therefore, no statistical significant differences
were found in support of the hypothesis. The frequency of cases with PSI scores greater
than GAI scores was fairly similar across groups and statistical comparisons did not
reveal any significant differences.
Table 41 contains a summary of the significant Index score splits found across
groups.

Table 41
Summary of Significant Index Score Splits
VCI > WMI

Nonmedicated ADHD vs.
Control 1*

Medicated ADHD vs.
Control 2*

Nonmedicated vs.
Medicated

10 points

10, 15 points

None

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2**

Nonmedicated vs.
Medicated

None
GAI > WMI

10, 15 points

None

Nonmedicated ADHD vs.
Control 1*

Medicated ADHD vs.
Control 2*

Nonmedicated vs.
Medicated ***

25 & 30 points

10 points

30 points

WMI > VCI
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WMI > GAI

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2**

Nonmedicated vs.
Medicated

None
PRI > PSI

15, 20 points

None

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2*

Nonmedicated vs.
Medicated ****

None
PSI > PRI

15, 20 points

10, 15 points

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2

Nonmedicated vs.
Medicated

None
GAI > PSI

None

None

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2*

Nonmedicated vs.
Medicated

None
PSI > GAI

10, 20, 25 points

None

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2**

Nonmedicated vs.
Medicated

None
VCI > PRI

30 points

None

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2*

Nonmedicated vs.
Medicated

None

15 points

--
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PRI > VCI

Nonmedicated ADHD vs.
Control 1**

Medicated ADHD vs.
Control 2

Nonmedicated vs.
Medicated

10, 15, 20 points
WMI > PSI

None

--

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2

Nonmedicated vs.
Medicated

None
PSI > WMI

None

--

Nonmedicated ADHD vs.
Control 1

Medicated ADHD vs.
Control 2

Nonmedicated vs.
Medicated

None

None

--

Note. Dashes indicate that comparison was not computed.
*Proportion of ADHD groups greater than non-ADHD groups. **Proportion of nonADHD group greater than ADHD groups. *** Proportion of nonmedicated ADHD group
greater than medicated ADHD group. ****Proportion of medicated ADHD group
greater than nonmedicated ADHD group.
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Chapter 4
Discussion
Summary of Results
The current study intended to examine the effects of ADHD and medication use
on the cognitive processing of children. This chapter includes a discussion of the results
in relation to the research questions of the study and hypotheses proposed. The
contributions to the field of psychology, limitations of the study, and recommendations
for future research are also addressed in this chapter.
The first set of research questions were designed to replicate Friedman’s 2006
study. Specifically, the first and second research questions involved an investigation of
the impact of ADHD diagnosis on FSIQ scores and factor scores (VCI, PRI, WMI, and
PSI) of the WISC-IV. Similar to Friedman’s (2006) study and in line with the
hypothesis, the current study did not find any significant differences between the mean
FSIQ scores of the two ADHD groups and their matched controls. Additionally, it was
predicted that there would be no significant differences between the ADHD groups and
their non-ADHD counterparts on the VCI, PRI, or PSI, but that there would be significant
differences between the ADHD groups and non-ADHD groups on the WMI. As
predicted, the results of the statistical analysis found no significant differences between
the mean VCI and PRI scores of the ADHD groups compared with their matched
controls. Statistical comparisons did reveal that the medicated ADHD group had
significantly lower mean WMI and PSI scores than their matched controls.
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The third research question involved an examination of how ADHD individuals
perform, relative to non-ADHD individuals on each subtest of the WISC-IV. Consistent
with Friedman’s (2006) finding, it was predicted that the mean scores of ADHD students
would be comparable with the mean scores of their non-ADHD counterparts on the
verbal reasoning subtests (VO, CO, SI), perceptual reasoning subtests (BD, MR, and
PCn), and processing speed subtests (CD and SS). Some differences were expected
between the ADHD groups and their non-ADHD controls on the working memory
subtests (DS and LNS). As hypothesized, no significant differences were found between
groups on the verbal reasoning or perceptual reasoning subtests. Statistical analysis did
find significant differences on the Letter Number Sequencing, Coding and Symbol
Search subtests. Specifically, the nonmedicated ADHD group evidenced significantly
lower mean scores on the LNS and CD subtests than their matched controls. The
medicated ADHD group evidenced significantly lower mean scores on the CD and SS
subtests than their matched controls.
The fourth and fifth research questions set out to investigate how medication
status impacts WISC-IV FSIQ and factor scores of students with ADHD. It was
hypothesized that the findings in this area would replicate Friedman’s findings so that no
significant differences would be found between the mean FSIQ scores or factor scores of
the medicated ADHD group and the nonmedicated ADHD group. The results of this
study supported these hypotheses because the ADHD medicated and nonmedicated
groups performed comparably on the WISC-IV FSIQ, VCI, PRI, WMI, and PSI.
The sixth research question sought to investigate the impact of medication on the
performance of ADHD students on the WISC-IV core subtests. Again, it was predicted
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that this study would replicate Friedman’s results. Specifically, no significant differences
were hypothesized between the mean subtests scores of the ADHD medicated and
nonmedicated groups for any of the 10 core WISC-IV subtests. The results of this study
supported the hypothesis because no significant differences between ADHD groups were
found across subtests.
A second set of research questions specific to the current study were also
investigated. These questions and hypotheses were based on the reviewed literature, that
overwhelmingly suggests that executive control deficits related to working memory and
processing speed are a core feature of ADHD and are related to neuropsychological
factors. Although the current study did find significant differences between the
medicated ADHD subjects and their matched controls on the WMI and PSI factors, the
effect sizes were small and significant differences were not found between the
nonmedicated ADHD group and their matched controls. There continued to be a
question, however, about how well the ADHD subjects performed on measures of
working memory and processing speed, relative to measures of other cognitive abilities.
Perhaps more significant working memory and processing speed impairments would be
found in ADHD students when these impairments are compared with verbal and
nonverbal reasoning skills. Thus, the second investigation was proposed to evaluate this
question. This research question was explored by comparing the Working Memory Index
and Verbal Comprehension Index score splits, the Working Memory Index and General
Ability Index score splits, the Processing Speed Index and Verbal Comprehension Index
score splits, and the Processing Speed Index and General Ability Index score splits
between the ADHD groups and their non-ADHD controls.
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Relative to the working memory splits, it was hypothesized that the proportion of
ADHD subjects with greater VCI and GAI scores relative to WMI scores would be larger
than the proportion of subjects in the matched control group with this pattern. The results
of the current study partially supported the hypothesis by finding that compared with
their matched controls, the nonmedicated ADHD group had significantly more cases of
VCI scores at least 10 points greater than WMI scores. The medicated ADHD group also
demonstrated significantly more cases of VCI scores at least 10 and 15 points greater
than WMI score when compared with their matched controls. It is important to note that
at other levels, even though the results were nonsignificant , the trend of the data
supported the stated hypothesis. Cases in which the WMI was greater than the VCI
happened more frequently in the non-ADHD groups. Specifically, there were
significantly more cases of WMI scores at least 10 or 15 points greater than VCI scores in
Control Group 2 than in their nonmedicated ADHD counterparts. The results of this
study also found more cases of GAI scores greater than WMI scores in the ADHD groups
than in the non-ADHD controls. Specifically, the nonmedicated ADHD group had
significantly more cases of GAI scores that were at least 25 and 30 points greater than
WMI scores, relative to their matched controls. The medicated ADHD group had larger
proportions of GAI scores, at least 10 points greater than WMI scores relative to their
non-ADHD counterparts. At other levels, even though not statistically significant, the
trend of the data supported the stated hypothesis. In contrast, there were more instances
of WMI scores greater than GAI scores by 15 or 20 points in the non-ADHD Control
Group 2 than in their nonmedicated ADHD counterparts.
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Relative to the Processing Speed Index splits, it was predicted that there would be
more cases of PRI scores greater than PSI scores in the ADHD groups than in the nonADHD control groups. Results of statistical analysis partially support the hypothesis.
There were significantly more cases of PRI scores that were at least 15 and 20 points
greater than PSI scores in the medicated ADHD group, relative to their non-ADHD
counterparts. At other levels, even though the findings were not statistically significant,
the trend of the data supported the stated hypothesis. Similarly, it was predicted that
there would be more occurrences of GAI scores greater than PSI scores in the ADHD
groups than in their non-ADHD counterparts. This hypothesis was also partially
supported in the current study, because there were significantly more subjects in the
medicated ADHD group with GAI scores who were at least 10, 20, and 25 points greater
than PSI scores relative to their non-ADHD counterparts. Also of some note, is the fact
that at other levels, the trend of the data supported the stated hypothesis, even though not
at a statistically significant level. In contrast, there were significantly more occurrences
of PSI scores at least 30 points greater than GAI scores in the non-ADHD control group
than in the medicated ADHD group.
Additional analyses were conducted to explore whether or not any pattern of
differences occurred between the VCI and PRI and between the WMI and PSI among
groups. The groups were predicted to have similar proportions of subjects with VCI
scores greater than and less than PRI scores and with WMI scores greater than or less
than PRI scores. Consistent with the hypothesis, the proportions of students with WMI
scores greater than or less than PSI scores were found to be statistically similar among
groups. Inconsistent with the hypotheses, the medicated ADHD group had a significantly
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greater proportion of subjects with VCI scores at least 15 points higher than PRI scores
relative to their non-ADHD control group. The non-ADHD Control Group 1 had more
cases of PRI scores at least 10, 15 or 20 points greater than VCI scores. Although this
finding was not predicted, a possible explanation of these differences could be that the
symptoms of ADHD are more likely to impact performance on the perceptual reasoning
tasks than on the verbal comprehension tasks. For example, the impulsivity and quick
response style symptomatic of ADHD may be more likely to hinder the greater attention
to detail that is required on the perceptual reasoning subtests. Further research is needed
to investigate this hypothesis.
In addition to comparing ADHD groups with non-ADHD groups, this study also
sought to evaluate whether or not differences occur in the cognitive profiles of children
with ADHD who are medicated versus those who are not. The first research question
related to this question stated, “To what extent does stimulant medication impact the
working memory capacity of ADHD children?” This question was explored by
comparing the VCI and WMI splits between the medicated ADHD group and the nonmedicated ADHD group. GAI and WMI score splits were also compared among groups.
Given the fact that medication treats the symptoms of ADHD, it was predicted that the
number of cases with VCI scores greater than WMI scores would be larger for the
nonmedicated or untreated ADHD group than for the medicated ADHD group. This
hypothesis was not supported. In fact, the proportion of subjects in the nonmedicated
ADHD group with VCI scores greater than WMI scores was comparable with the
proportions of subjects with this difference in the medicated ADHD group. There were
also no significant differences among groups relative to the proportion of cases with
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WMI scores greater than VCI scores. Relative to the GAI- WMI splits, it was predicted
that the proportion of cases with GAI scores greater than WMI scores would be larger for
the nonmedicated ADHD group than for the medicated ADHD group. Results partially
supported this hypothesis. There were significantly more nonmedicated ADHD subjects
than medicated ADHD subjects with GAI scores at least 30 points greater than WMI
scores. The proportion of subjects with WMI scores greater than GAI scores was
comparable among groups.
The final research question sought to examine the extent to which stimulant
medication impacts processing speed in ADHD children. This question was explored by
examining the PSI scores versus measures of other cognitive abilities for medicated
ADHD individuals versus nonmedicated ADHD individuals. It was predicted that the
number of cases with PRI scores greater than PSI scores would be larger in the
nonmedicated group than in the medicated group. This hypothesis was not supported.
There were actually significantly more students in the medicated ADHD group with PRI
scores greater than PSI scores by at least 10 or 15 points. The proportion of cases with
PSI scores greater than PRI scores was similar across ADHD groups. Finally, it was
predicted that the number of subjects with GAI scores greater than PSI scores would be
larger in the nonmedicated ADHD group than in the medicated ADHD group. This
hypothesis was also not supported. The proportion of students with GAI scores greater
than PSI scores was similar across groups.
Significance of the Results
The current study replicated Friedman’s (2006) finding that the FSIQ scores of
ADHD students are comparable with those of non-ADHD students. This finding is
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contrary to previous research that found lower FSIQ scores in ADHD samples (i.e.,
Barkley, 1990; Barkley, DuPaul & McMurray, 1992, Faraone, et al., 1993; Tripp, Ryan
& Peace, 2002; Zhuang, Liu & Zhang, 2001; and Zimmerman & Woo-Sam, 1997).
Although processing speed and working memory, thought to be most vulnerable to
symptoms of ADHD, weigh more heavily on WISC-IV FSIQ calculations than previous
versions of the Wechsler Scales, they still contribute less weight than the verbal
reasoning and perceptual reasoning subtests. Specifically, working memory and
processing speed each make up 20% of FSIQ, and verbal reasoning and perceptual
reasoning each make up 30% of FSIQ. This difference in weight makes it less likely that
working memory and processing speed deficits will be reflected in significantly lower
FSIQs.
Friedman (2006) attributed her lack of significant findings related to FSIQ in
ADHD versus non-ADHD subjects, which was contrary to previous research, to
methodological differences. Unlike the previous studies, Friedman matched ADHD and
non-ADHD subjects on demographics and ability levels through the VCI, whereas
matching in other studies occurred only on demographic variables. She suggested that
had ability levels been allowed to vary in an uncontrolled manner, results may have
possibly been different. Similar to Friedman’s study, this study also matched controls on
the ability level through VCI and supports her suggestion that under the more rigorous
condition of matching subjects by VCI, the addition of PRI, WMI and PSI tasks did not
result in decreases in the FSIQ of ADHD children relative to non-ADHD individuals.
The current study also replicated Friedman’s (2006) finding that medication did
not have a significant impact on FSIQ. There were no differences between the FSIQ’s of

Cognitive Profiles of ADHD Students

111

the medicated ADHD group and nonmedicated ADHD group. These findings are in
contrast to previous studies which have suggested that the use of medication could have a
significant effect on FSIQ score of ADHD children (i.e., Faraone, 2003; Gillberg, et. al.,
1997). Friedman attributed the inconsistency to methodological differences, such as lack
of random assignment to medicated/ nonmedicated group comparisons and possibly to
small effect sizes of significant group differences. Further, Gillberg and colleagues
(1997) used a long-term, placebo-controlled study that found improved results on the
WISC-R with medicated ADHD children; however, the sample size was small, and type
II error could not be excluded as a possible source of the differences. The current study
utilized procedures similar to Friedman; therefore, differences between the current study
and previous studies showing contrary findings may also be attributed to methodological
differences.
At the Index level, this study found significant differences among the ADHD
groups and their controls on WMI and PSI, specifically between the medicated ADHD
group and their matched controls. On the WMI, although overall scores were not
significantly different between the nonmedicated ADHD group and their matched
controls, there were significant differences between groups on the LNS subtest. This
finding is somewhat consistent with the literature (Kail & Salthouse, 1994; Kail &
Salthouse, 1994; Kail, 2000; Kalff et al., 2002; Karatekin & Asarnow, 1998; Martinussen
et al., 2005; Rucklidge & Tannock, 2001; Weiler et al., 2002), suggesting that ADHD is
associated with problems in verbal working memory and slower retrieval speed. It is also
consistent with studies utilizing the WISC-III (Anastopoulos et al., 1994; Mayes et al.,
1998; Reinecke, Beebe, & Stein, 1999) and WISC-IV (J. Friedman, 2006; J. Friedman,
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2006; Wechsler, 2003), which found WMI scores to be weaker in ADHD subjects than in
non-ADHD groups. Although the current findings are in line with previous research,
more significant differences were expected at the subtest level than were actually found,
specifically on the Digit Span subtest. Previous research using the WISC-III found that
ADHD subjects had lower mean scores on the Digit Span subtest (Kaufman, 1994;
Mayes et al., 1998; Wechsler, 1991; Wechsler, 1991) than non-ADHD subjects. On the
other hand, the WISC-IV standardization studies comparing the ADHD group with other
groups found only small effect sizes for Digit Span (Wechsler, 2003). Furthermore,
Friedman (2006) found some significant differences on the Digit Span subtest between
the ADHD and non-ADHD groups, although further analysis found that this difference
was related to performance only on Digit Span Forward.
Also, in support of the research implicating weaknesses in working memory in
ADHD subjects, this study found that subjects with ADHD were more likely than their
non-ADHD controls to exhibit Working Memory Index scores relatively lower than
measures of other cognitive abilities such as the Verbal Comprehension and the
combination of verbal comprehension and perceptual reasoning tasks in the form of the
General Ability Index. This is consistent with previous research, using the WISC-III,
which found that ADHD subjects scored relatively weaker on the Freedom from
Distractibility Index than on other factors, such as the Verbal Comprehension and
Perceptual Organization Index (Anastopoulos et al., 1994; Krane & Tannock, 2001;
Reinecke et al., 1999). In the current study, cases of WMI scores greater than the VCI
and/ or GAI scores occurred more frequently in the non-ADHD groups.
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On the Processing Speed Index, the medicated ADHD group had significantly
lower PSI scores than their matched controls. At the subtest level, there were significant
differences between both the nonmedicated and medicated ADHD groups and their
matched controls on the CD subtest, but only between the medicated ADHD group and
their matched controls on the SS subtest. This is in contrast to Friedman’s findings,
which did not reveal significant PSI differences between groups. This finding is,
however, in line with the results of the WISC-IV clinical study reported in the
standardization manual (Wechsler, 2003), in which there was a moderate effect size for
group mean differences on the PSI. The standardization study of the WISC-IV
(Wechsler, 2003) also found one of the largest effect sizes at the subtest level for group
mean scaled score differences on the Coding subtest. Other research (Krane & Tannock,
2001; Mayes, Calhoun & Crowell, 1999) also found significantly lower mean subtest
scores for ADHD groups on the processing speed subtests of Coding and Symbol Search.
Further support of the research suggesting that processing speed is impacted in
students with ADHD, is offered by the current finding that subjects with ADHD were
more likely to display lower scores on the Processing Speed Index, relative to their scores
on the Perceptual Reasoning and General Ability Index. Specifically, there were
significantly more subjects in the medicated ADHD group with PRI scores greater than
PSI scores. There were also significantly more medicated ADHD subjects than subjects
in the control group who had GAI scores greater than PSI scores. This same finding,
however, did not apply to the nonmedicated ADHD group when compared with their
controls.
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Related to the effects of medication on the cognitive functioning of ADHD
students, previous studies evaluating the short-term effects of methylphenidate on WISCIII performance failed to reveal significant treatment effects for subtest, index, or VIQ
and PIQ scores (Saklofske & Schwean, 1993; Schwean et al., 1993). In fact, Prifitera and
colleagues (2005) speculated that, given the results of studies indicating the lack of
medication effects on WISC-III performance, it would be unlikely that the WISC-IV
ADHD clinical study, which included a large percentage of children being treated with
medication, would find medication effects. The WISC-IV standardization sample,
however, was not separated by medication effects; therefore, no conclusions could be
drawn about medication effects of ADHD students on the WISC-IV. Friedman’s (2006)
study also did not find significant medication effects on the FSIQ, Index, or Subtest
scores (with the exception of DSF) for subjects with ADHD. On the other hand, Faraone
(2003) did report large effect sizes for stimulant medication on intelligence scores;
however, other literature supporting this type of effect is sparse.
Consistent with much of the other literature, the current study did not find
significant differences on overall measures of cognitive functioning between ADHD
students who were medicated versus those who were not. There were no differences in
FSIQ or Index scores. There were also no significant differences found between the
medicated and nonmedicated subjects at the subtest level. Working Memory Index and
Processing Speed Index performance was also compared in nonmedicated and medicated
ADHD subjects to measures of other cognitive abilities such as Verbal Comprehension
Index, Perceptual Reasoning Index and General Ability Index. Nonmedicated subjects
were more likely than medicated subjects to display GAI scores greater than WMI. This
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provides some support for the positive effects of medication on working memory,
although much more research is needed to make this claim. On the other hand, no
support for positive medication effects on processing speed was found in this study. In
fact, the medicated subjects were actually more likely than nonmedicated subjects to
display PSI scores lower than PRI scores. One reason for the lack of significant findings
between the medicated and nonmedicated ADHD groups could be due to sample
differences. For example, this study did not match medicated and nonmedicated subjects
on any demographic variables or on severity of ADHD symptoms. Thus it is possible
that underlying differences between samples on these variables obscured medication
effects. The students taking medication often had other comorbid disorders and some
were taking multiple medications, suggesting that perhaps their symptoms were greater to
begin with. Also important to consider is that medication is more frequently prescribed
for hyperactive/ impulsive symptoms than only for inattentive symptoms. Thus it is
possible that the medicated ADHD group had more cases of ADHD-HIT or ADHD-CT,
whereas the nonmedicated ADHD group may been more heterogeneous, containing more
of a mixture of ADHD-HIT, ADHD-IT, and ADHD-CT. Thus both subtype of ADHD
and severity of symptoms could be confounding variables. Finally, the number of cases
in each group at each level was relatively small, which may also have limited the
statistical findings. Further research evaluating medication effects while controlling for
other potential confounding variables is needed to improve our understanding of the
impact of medication on cognitive functioning.
Contributions to the Field
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This study was one of a few that have matched controls to ADHD subjects on
both demographic variables and verbal ability levels in order to examine the performance
of ADHD students relative to non-ADHD students and to examine the performance of
nonmedicated ADHD students relative to medicated ADHD students on measures of
intelligence, working memory, and processing speed. Also evaluated in this study was
performance on working memory and processing speed relative to measures of other
cognitive abilities. This study both replicated and expanded Friedman’s research,
providing further evidence for the presence of some differences in the cognitive profiles
of ADHD students versus students without the disorder. Although not as many
significant results as expected were found, there was a clear trend (as evidenced both by
significant results and by results approaching significance) of weaker Working Memory
Index and Processing Speed Index scores in the ADHD groups relative to their nonADHD counterparts and relative to their other cognitive abilities such as the abilities to
reason with verbal and nonverbal information. In fact, in no cases did the collected data
refute the expected pattern of ADHD groups as having greater Index score splits than
non-ADHD groups. Although further research with larger sample sizes is needed to
confirm this trend, this study coupled with Friedman’s study, does suggest that relative
weaknesses in working memory and processing speed may be a useful diagnostic marker,
when combined with other corroborating data, for ADHD.
This study failed to find many differences between medicated ADHD subjects
and nonmedicated ADHD subjects. Because medication has been found to lessen the
symptoms of ADHD, it would make sense that this would carry over into improvement in
some aspects of cognitive functioning. This study lent some mild support for positive
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effects of medication on auditory working memory; however, this same finding did not
hold true for processing speed. The finding that medicated ADHD subjects did not
evidence less impaired processing speed than nonmedicated ADHD subjects could
suggest that medication use does not, in fact, improve visual processing. On the other
hand, these results could be related to limitations of the study design and sample
characteristics that obscured medication effects. Much more research is needed to
investigate processing speed and medication use in ADHD subjects.
Although the findings of this study seem to suggest that students with attentional
disorders may be more likely to experience working memory and processing speed
problems, it is important to consider individual cases in clinical practice. Not all ADHD
students display this trend. Likewise, students with other types of disabilities could
display this trend. Therefore considering cognitive patterns along with other data such as
classroom behavior, developmental history, academic achievement, parent and teacher
input, and executive function capacities is essential for differential diagnosis.
Limitations
Limitations of this study include the fact that cross-sectional comparisons of
group data were analyzed rather than longitudinal data for treatment and control groups.
Medication effects may be better ascertained by testing an ADHD group prior to and then
after medication treatment begins and comparing pre-post differences with a control
group.
Another limitation is the method of ADHD diagnosis. ADHD diagnosis of
subjects could be made by the clinician assessing the child (i.e., school psychologists) or
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through prior evaluation by another provider. Therefore consistency in diagnostic
practice cannot be evaluated and may be variable across practitioners.
Only subjects with comorbid mental retardation or VCI scores below 80 were
excluded from the study. Subjects with comorbid diagnoses such as learning disabilities,
emotional disturbances, and Aspergers Disorder were not excluded in the current study,
which raises the possibility that co-occurring disorders may have their own effects on
reasoning, working memory, and processing speed.
Given the constraints of the data available, subjects with all three subtypes of
ADHD (ADHD-IT, ADHD-HIT, and ADHD-CT) were included in this study and were
grouped together. There is some evidence to suggest that ADHD-IT is distinct from
ADHD-HIT and ADHD-CT (Barkley, DuPaul & McMurray, 1992), with ADHD-IT
possibly having a more negative impact on cognitive processes. Thus, subtype of ADHD
can present a confounding variable.
Gender differences were not explored because of difficulty obtaining large
samples equally representative of both genders. Given the fact that greater intellectual
impairments have been found in girls with ADHD than in boys (Biederman et al., 1999;
Gaub & Carlson, 1997), results which include females may yield different results.
This study also did not analyze the impact of different types, name brands, or
combinations of medication on cognitive functioning. The medicated ADHD group
included students taking a variety of medications/ combinations of medications. Future
research is needed to analyze the impact of different medications and combinations of
medications on the cognitive functioning of ADHD individuals.
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Finally, it is important to note that in conducting the analysis of factor score splits,
the n values at each level were relatively small. With larger sample sizes, it is possible
that more robust differences between ADHD and non-ADHD groups would be found.
Future Directions for Research
Further research with larger sample size is needed to investigate the VCI/ WMI,
GAI/WMI, PRI/ PSI, GAI/PSI splits found in ADHD children. A focus on subtest score
patterns will be particularly useful. If the findings of this study are replicated across
other samples, clinicians can better understand the cognitive profiles of ADHD children.
There is also a need to evaluate the cognitive profiles both of younger and of
older ADHD subjects to see if these findings hold true for all age groups. Research
evaluating the cognitive profiles of ADHD females of all ages is needed to understand
gender differences. Furthermore, an evaluation of different types and combinations of
medication on cognitive functioning is needed to understand further, the impact of
medication on cognitive functioning. Finally, an evaluation of the cognitive functioning
of ADHD subjects, utilizing intelligence measures other than the Wechsler Scales is
indicated. Current practice for diagnosing ADHD is based primarily on behavioral
factors, which has many limitations. Understanding the cognitive indicators of ADHD
will enhance the diagnostic practice of clinicians in the field.
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